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1 SUMMARY 
 
Filamentous actin (F-actin) is an important part of the eukaryotic cytoskeleton and is 
crucial for fundamental processes including morphogenesis, cell division and cell 
migration. In the recent years live-cell imaging became more and more important to 
analyze those processes but previously established markers for F-actin have several 
drawbacks.  
In the first part of my PhD thesis, I characterized a newly discovered actin binding 
domain of the yeast actin-binding protein Abp140, comprising only 17 amino acids 
(aa), as potential actin marker (Lifeact). In biochemical assays, using a chemically 
synthesized peptide (FITC-Lifeact), no disturbing effects on polymerization or 
depolymerization of actin could be detected which was also in line with the low 
binding affinity to F-actin. Moreover, the binding affinities of Lifeact on G- and on F-
actin were not altered by various actin binding proteins and drugs. In different cell 
types - transiently or stably transfected -, all known actin structures were labelled as 
visualized by different microscopic techniques, e.g. epifluorescence, confocal or total 
internal reflection fluorescence microscopy. In addition the chemically synthesized 
FITC-Lifeact could be used to stain F-actin in fixed cells and tissues as well as in living 
cells thus enabling analysis of actin dynamics in non-transfectable cells. Demonstrating 
the suitability of Lifeact as non-intrusive actin marker, three sensitive read-outs for 
cytoskeletal impairments - neuronal polarization, retrograde actin flow and speed of 
chemotactic cells - were not affected by strong Lifeact-EGFP expression. 
Furthermore, Lifeact is the shortest actin marker so far described exhibiting no 
homologous sequences in higher eukaryotes. Summarized, for most applications 
Lifeact can be considered as the best actin marker available to date. 
The second part of my work dealt with the generation of Lifeact-EGFP and Lifeact-
mRFP transgenic mice as tools for analysis of actin dynamics in primary cells, tissues 
and whole animals. Hence, to obtain an ubiquitous expression of the marker a 
construct containing the chicken-β-actin promoter was used for microinjection which 
results in random integration into the genome. Investigation of the fluorescent signal 
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on organ level in the different mouse lines revealed variable expression patterns. 
Nonetheless, all mice were perfectly viable, phenotypically normal and fertile. 
Founders with the most ubiquitous expression of Lifeact were characterized in detail. 
Microscopic analysis revealed that all tested cell types showed a bright and specific 
labelling of their actin cytoskeleton. Moreover, strong expression of Lifeact could 
already be observed during early embryonic development. Finally, isolated primary 
cells from transgenic mice were tested for neuronal polarization and chemotactic 
migration and showed no significant differences to wildtype controls indicating that 
actin dynamics were not altered. Based on these observations, the generated transgenic 
mice can be used as universal tool for analyzing actin dynamics in various disciplines. 
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2 INTRODUCTION  
 
2.1 Actin and the cytoskeleton 
 
Actin is one of the most abundant proteins in eukaryotic organisms and is important 
for their survival. It is well established that actin is a central player in many different 
aspects of cell morphogenesis, cell division or cell migration (Pollard & Cooper 2009; 
Molecular Biology of the Cell, 2002). Recently it was described that actin homologues 
are also present in prokaryotes being important for morphogenesis and cell polarity 
(Jones et al. 2001, van den Ent et al. 2001).  
Actin is one of the three major components of the cytoskeleton together with 
microtubules and intermediate filaments. In eukaryotes the amino acid sequence of 
actin is highly conserved, however there are some variations on the level of gene 
number: single-celled organisms such as yeast contain only one actin encoding gene 
(Gallwitz & Sures 1980) whereas multi-cellular organisms have several functional 
genes (Gunning et al. 1983). Moreover, higher eukaryotes have three protein isoforms 
of actin: α-, β- and γ-actin. While α-actin is restricted to muscle cells, β- and γ-actin are 
present in all cell types. 
Actin is a 43 kiloDalton (kDa) protein comprising 375 amino acids (aa) and is found in 
a monomeric, globular state (G-actin, Figure 2.1) in the cell. The analysis of the x-ray-
diffraction of an actin crystal revealed that it consists of four subdomains (1-4; Kabsch 
et al. 1990). A cleft between subdomains 2 and 4 is the binding site for adenosine-tri-
phosphate (ATP) where it is hydrolyzed to adenosine-di-phosphate (ADP) (Figure 
2.1). The conformation of the actin structure is dependent on the nucleotide state.  
 
ATP-bound G-actin is able to polymerize into filaments (filamentous actin, F-actin). 
These are made of two protofilaments that form a right-handed helix with a diameter 
of 7-10 nanometers (nm). Intracellularly, there is a strong variation of filament length 
which depends on many cellular cofactors (discussed in section 2.2). 
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Figure 2.1 Structure of the actin monomer. Ribbon (left) and space-filling (right) models of 
the actin molecule (pdb:1ATN) bound to ATP. This structure was derived from an 
actin:DNaseI complex (Kabsch et al. 1990). 
 
Source Image: Pollard et al. 2009 
 
The mechanisms of F-actin polymerization have mostly been elucidated by in vitro 
experiments on purified actin (Carlier 1991, Pollard 1986). In general, polymerization 
of actin filaments has two phases. The first phase is a nucleation phase, in which actin 
dimers and trimers are formed. Dimerization and trimerization are thermodynamically 
unfavourable, making nucleation the rate-limiting step of polymerization (Sept & 
McCammon 2001; Figure 2.2. Hence, under physiological conditions cofactors (e.g. 
nucleation factors, see section 2.2) are required to support this process. Once four 
actin monomers interact, the polymer becomes stable and the second phase of 
polymerization, the elongation phase, is favoured (Figure 2.2, Wegner & Engel 1975). 
The rate of filament elongation is diffusion-limited, i.e. is directly proportional to the 
concentration of available monomers. 
As a result of the asymmetry of the actin structure, elongation is also asymmetric with 
one side polymerizing much faster (barbed end) than the opposite side (pointed end; 
Drenckhahn & Pollard 1986). This is due to the inherent polarity of filaments in 
which all actin monomers are incorporated in the same orientation (Gardet et al. 
2007). Hence, monomer addition at the barbed end requires only 0.1µM of ATP-G-
actin whereas growing on the pointed end is not established below 0.6µM of ATP-G-
actin (Pollard 1986). At an intermediate ATP-G-actin concentration, continuous 
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growth on the barbed-end is maintained while the pointed-end shrinks. In this 
process, called treadmilling, the filament length remains approximately constant. 
Balancing this simultaneous association and dissociation requires a higher monomer 
concentration at the pointed end than at the barbed end (Neuhaus et al. 1983).  
 
 
 
Figure 2.2 Spontaneous nucleation and elongation of actin. Actin dimers and trimers are 
unstable complexes and therefore they are very likely to collapse. When a polymer of four 
monomers is established it starts to grow rapidly at the barbed end (B) and slowly at the 
pointed end (P). 
 
Source Image: Pollard et al. 2009 
 
Once ATP-G-actin is incorporated into a filament, the ATP is slowly hydrolyzed to 
ADP. Treadmilling is powered by this hydrolysis and the resulting energy can be 
utilized to perform cellular processes. This motion generates force which can be used, 
for example in migrating cells at the leading edge to promote protrusions (Molecular 
Biology of the Cell 2008). However, the time-scale of assembly and disassembly in vivo 
is in order of magnitudes faster than in vitro where only actin is present and this 
enhancement is the task of many cellular cofactors (Dos Remedios et al. 2003). 
Additionally, all actin-related cellular processes are dependent on such cofactors, either 
to promote or to prevent them. Therefore, several important cofactors are introduced 
in section 2.2. 
 
2.2  Regulators of actin polymerization 
 
It is fundamental for cells to highly regulate actin polymerization to prevent 
uncontrolled generation of filaments. Therefore many regulatory proteins are involved 
in this process such as sequestering proteins, nucleation factors, capping, severing, 
crosslinking or motor proteins. 
 
 
Introduction 
 
 - 14 - 
Sequestering proteins 
 
Sequestering proteins (e.g. profilin, thymosin β4) are able to bind to actin monomers 
and are important for maintaining a pool of monomers in solution. Profilin, for 
example, promotes actin polymerization by binding G-actin and bringing it to the 
barbed end of a filament. Moreover, profilin also catalyzes the exchange of ADP for 
ATP by altering the conformation of G-actin, opening its nucleotide binding site to 
the cytosol. Thus, profilin activity increases the local concentration of ATP-G-actin 
which can subsequently be used for incorporation into new filaments (Sagot et al. 
2002; Pantaloni & Carlier 1993).  
 
Nucleators 
 
Nucleation factors are crucial for overcoming the rate-limiting step, trimerisation 
(Figure 2.3a). There are three different classes known today: the actin-related protein 
(Arp) 2/3 complex (Mullins et al. 1998), formins (Pring et al. 2003) and Wiskott-
Aldrich syndrome protein (WASP) homology 2 (WH2) domain nucleators (e.g. spire, 
leiomodin or cordon-bleu (Kerkhoff 2006, Qualmann & Kessels 2009). The Arp2/3-
complex consists of seven subunits whereby the Arp 2 and 3 structurally resemble 
actin and bind to actin monomers. Consequently, they are thought to act similar to an 
actin-dimer and therefore serve as nucleation site. During polymerization the Arp2/3 
complex remains at the pointed end of a filament. Unique for this complex is the 
ability to bind to pre-existing actin filaments and nucleate new branched filaments and 
thereby enabling the building of dendritic networks (Figure 2.3b; Pollard 2007).  
Formins are single, multi-domain polypeptides and constitute a large and diverse 
protein family (Chalkia et al. 2008, Higgs & Peterson 2005). They act as homodimers 
mediated through their formin-homology 2 (FH2) domains which also serve as 
binding sites to actin (Pruyne et al. 2002). This homodimer is very likely to function by 
stabilizing spontaneously formed actin dimers or trimers (Figure 2.3c; Xu et al. 2004). 
Interestingly, formins remain at the barbed end through a proposed stair stepping 
mechanism (Otomo et al. 2005), and thereby enable further elongation while 
preventing the binding of capping proteins (see later in this section; Pring et al. 2003). 
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The rates of nucleation and elongation vary greatly between different formins (Goode 
& Eck 2007). 
Most recently discovered is a third group of actin nucleators that are also single 
polypeptides containing WH2-domains. These proteins contain multiple actin binding 
regions (WH2 motives) and are thought to recruit or align actin monomers. For 
example, in the case of spire, these monomers are aligned in a tetrameric 
polymerization ‘seed’ (Figure 2.3d; Qualmann & Kessels 2009). To date, little is 
known about the mechanisms utilized by these nucleation factors. Notably, filaments 
assembled by formins and also by WH2 nucleators are nonbranched (Pring et al. 2003, 
Qualmann & Kessels 2009). 
 
 
 
Figure 2.3 Different actin nucleation mechanisms. (a) Actin monomers alone nucleate 
very slowly but when four monomers interact filament growth is favored. (b-d) In all cases the 
nucleation step is catalyzed by cofactors. (b) Arp2/3 complex is thought to mimic an actin-
dimer or -trimer to serve as a template for polymerization for de novo and branched filaments. 
(c) Studies of the formins suggest that a dimer - built through binding of their FH2-domains – 
stabilizes an actin-dimer or-trimer and thereby facilitates the nucleation step. (d) As one of the 
WH2 nucleators, spire contains four WH2-domains which bind four actin monomers and 
functions as a scaffold for polymerization into unbranched filaments.  
 
Source Image: Goley & Welch 2006 
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Capping proteins 
 
Once a filament is formed and the ends are exposed to the cytosol, capping proteins 
(e.g. CapZ capping protein, tropomodulins) may bind there (Figure 2.4). They 
function either in stabilizing the actin filament or in promoting its disassembly. CapZ, 
for example, binds to the barbed end of an actin filament thereby preventing further 
elongation. Then, the filament shortens if the dissociation of actin monomers 
continues at the pointed end (Hart & Cooper 1999). In contrast, tropomodulins cap 
the pointed ends of filaments preventing dissociation of monomers and leading to 
further elongation. 
 
Severing proteins 
 
These proteins bind to the side of filaments and sever them into pieces (e.g. cofilin, 
gelsolin) contributing to filament shortening. For example, cofilin belongs to the actin-
depolymerizing factor (ADF) protein family and is essential for a rapid turnover of F-
actin (Lappalainen & Drubin 1997; Ghosh et al. 2004). Cofilin is also able to capture 
ADP-G-actin, thereby promoting its dissociation from the pointed end. The inhibition 
of the exchange from ADP to ATP by bound cofilin prevents then re-polymerization. 
On the one hand, these mechanisms serve to rapidly depolymerize filamentous actin; 
on the other hand, the resulting shorter filaments can be used to quickly reorganize 
the existing structure, e.g. parallel bundles into a dendritic network (Figure 2.4). 
 
Crosslinking proteins 
 
Crosslinking proteins (e.g. α-actinin, filamin) organize existing filaments into bundles 
or networks. Most of them function as dimers or need at least two actin-binding sites 
to connect actin filaments. For example, α-actinin organizes filaments into parallel 
bundles (Figure 2.4). In contrast, filamin functions as a dimer with an inherent 
flexibility of its structure thereby enabling the formation of loose networks of actin 
filaments (Figure 2.4; Esue et al. 2009). 
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Figure 2.4 Dynamics of actin filaments. Once a filament is formed several processes can 
occur: Capping proteins bind to and block barbed or pointed ends; cofilin depolymerizes and 
severs filaments; cross-linking proteins assemble networks and bundles of actin filaments.  
 
Source Image: Pollard et al. 2009 
 
 
Motor proteins 
 
Motor proteins are the driving force behind most active processes in cells. Certain 
motor proteins such as the myosin family use actin filaments as tracks to move. 
Myosins constitute a large superfamily of molecular motors and - besides an actin-
binding domain - they contain an ATPase to generate force to “walk” on actin 
filaments in the direction of the barbed end – except for myosin VI which moves 
towards the pointed end. Mediated through their tail domain, myosins are also able to 
interact with and to transport cellular cargos (Berg et al. 2001, Sellers 2000). 
 
 
In summary, the regulation of actin filaments is a highly complex system and involves 
a large number of regulatory proteins to establish a functional cytoskeleton. Versatile 
structures can be generated in cells with these filaments which are described in section 
2.3.  
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2.3 F-actin structures in mammalian cells 
 
In eukaryotic cells the helical actin filaments can be arranged in many different higher-
order cellular structures. These arrangements can be divided into three basic groups: 
Parallel bundles (filaments with the same orientation), antiparallel bundles (filaments 
with opposite orientation) and dendritic networks of filaments (Chhabra & Higgs 
2007).  
 
Cells utilize these different arrangements of actin filaments to perform distinct 
processes. These processes can generally be distinguished in two categories: either 
protrusions leading to expansion of the cell membrane or contractions leading to its 
shrinkage.  
For example, microvilli and filopodia are finger-like protrusions. The latter are often 
found in motile cells, like fibroblasts or neurons. They are generated by parallel 
bundling of many actin-filaments and are believed to function as directional sensors 
(Figure 2.5; Zheng et al. 1996). 
Non-muscle cells contain many stress fibers which consist of crosslinked, antiparallel 
actin filaments. Stress fibers obtain their contractility through interaction with the 
motor protein myosin II and are major mediators of cell contraction. However, in the 
last few years, it has become more and more clear, that there are different forms of 
stress fibers with distinct functions present in cells (Figure 2.5; Pellegrin & Mellor 
2007).  
A highly dendritic network of actin filaments is used in lamellipodia which are sheet-
like protrusions of the cell membrane. They are generated by cells during spreading or 
migration (Figure 2.5; Abercrombie et al. 1971, Bailly et al. 1998). Endosomes and 
phagocytic cups are also proposed to contain dendritic networks of actin. The latter 
structure serves to take up large, extra-cellular particles conducted by macrophages, 
for example (Figure 2.5; Aderem & Underhill 1999). Endosomes are required for 
internalization of small particles, such as receptors, located at the plasma membrane of 
eukaryotic cells. Then, these particles are either degraded in lysosomes or recycled 
back to the plasma membrane (Figure 2.5; Grant & Donaldson 2009; Hicke & Dunn 
2003).    
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Figure 2.5 Actin structures in a hypothetical cell. F-actin structures in a cross-section of a 
hypothetical motile metazoan cell: The cell is migrating upwards and is associated to a second 
cell on the right side. Actin-based structures which are also present in non-motile cells are e.g. 
nuclear actin, golgi-associated actin, endosomal-associated actin and phagocytic cup associated 
actin. Actin structures restricted to motile cells are e.g. the lamellipodium, lamellum, filopodia 
and ruffles.  
 
Source Image: Chhabra & Higgs 2007 
 
Most recently, it has become evident that F-actin is also present in the nucleus and 
contributes to processes such as RNA transcription or chromatin-remodelling. To 
date, the underlying mechanisms still remain to be elucidated. However, actin might 
have a distinct conformation to the cytoplasmic filamentous actin (Figure 2.5; 
Bettinger et al. 2004). 
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2.4 F-actin is involved in many cellular processes and diseases 
 
Being involved in many different cellular structures it is not surprising that F-actin 
plays a crucial role in fundamental cellular processes. For example, cell shape, division, 
polarization and migration are processes critically dependent on F-actin. It is obvious 
that the cell morphology is based on a versatile and stable cytoskeleton which is 
formed by filamentous actin - besides microtubule and intermediate filaments (Figure 
2.6a; Pollard & Cooper 2009). Moreover, the cytoskeleton enables cells to sense 
external forces and mechanical properties of the environment which influences the 
cells reactions. As an example, cell differentiation into various types is influenced by 
the stiffness of the substrate (Discher et al. 2009).  
 
Mitosis is important for successfully developing and maintaining an organism and is 
another process where F-actin is involved. This process has to be highly organized 
temporally and spatially. It is known that F-actin plays a role in spindle orientation, 
chromosome segregation and cytokinesis when contraction is required to split one cell 
into two (Hwang et al. 2003). The latter step is dependent on the formation of a 
contractile ring between the two daughter cells which is mainly composed of F-actin 
and associated proteins, such as myosin II (Figure 2.6b; Sanger et al. 1989).  
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Figure 2.6 F-actin is important for many cellular processes. (a) F-actin is a major 
component of a cellular cytoskeleton which helps to form different cell shapes not only in 
mammalian cells. Depicted are epithelial cells, red blood cells, muscle cells, a neuron and 
lymphocytes. (b) Mitosis is another process where F-actin (visualized in red) is involved. 
Especially during cytokinesis the cell depends on the contractile ring which is mainly formed 
by filamentous actin (chromosomes in blue). 
 
Source Image a: modified from www.nationalacademies.org/stemcells 
Image b: modified from Yang et al. 2004  
 
Cell polarization depends on specific spatial signals provided by the environment 
(such as gradients of chemoattractants) or cell history (such as bud scars in yeast). 
These signals have to be transmitted to various cellular objectives whereby the actin 
cytoskeleton is one of the major targets. As a response to signals, the rearrangement of 
actin leads to the establishment of a polarized morphogenesis (Wedlich-Soldner & Li 
2004). 
Polarization is also a prerequisite for cell migration which is an important biological 
process being involved in various processes like the development of organisms, 
immune system functions and diseases (Weiner et al. 2006, Lauffenburger & Horwitz 
1996). Some cells, such as leukocytes, move as fast as 40 µm per minute in vitro; 
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however, their speed is most likely slower in vivo. This migration depends on force 
generation and on its transmission to the extracellular substratum of the migrating cell. 
The current main model explaining these forces is based on the dynamics of the actin 
cytoskeleton but different hypotheses are proposed as well in this field (Mogilner & 
Oster 2003; Lammermann et al. 2008). Thus, the details of the complex mechanism of 
cell migration remain to be elucidated. 
 
Being involved in many cellular processes, it is not surprising that also many diseases 
can be linked to actin dysfunctions including Alzheimer disease (James R. Bamburg & 
Bloom 2009), autosomal dominant deafness (Zhu et al. 2003), dilated and 
hypertrophic cardiomyopathy (Olson et al. 1998 and 2000) as well as cancer (Suresh 
2007). 
 
2.5 Visualization of F-actin in fixed and living samples 
 
With the increasing importance of video-microscopy and cell-based screening, it has 
become more and more essential to visualize F-actin in living cells. Hence, actin 
dynamics can be easily quantified. Moreover, processes such as cell polarization or cell 
migration can only be thoroughly studied by live-cell imaging. For this purpose, 
researchers have either relied on the injection of fluorescently labelled actin or small 
amounts of phalloidin or on the use of genetically encoded fluorophore-coupled actin-
binding proteins. 
The first described and up to now commonly used probe for F-actin in fixed cells and 
tissues is phalloidin coupled to fluorophores (Faulstich et al. 1980). This phallotoxin, 
isolated from the mushroom death cap (Amanita phalloides), binds specifically to F-actin 
allowing reliable visualization of the actin cytoskeleton, while at the same time 
stabilizing actin filaments. However, actin in cells such as the plant pathogenic fungus 
Ustilago maydis or the parasites plasmodium or leishmania cannot be stained by phalloidin 
(Weinzierl et al. 2002; Schüler et al. 2005; Kapoor et al. 2008).  
The usage of phalloidin or fluorescently labelled actin in living samples is limited to 
injectable large cells, requires specialized equipment and relatively expensive probes. 
Moreover, working with phalloidin has several limitations. As a toxin, this protein 
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affects the cell by irreversibly stabilizing the actin filaments thereby leading to cell 
death. Therefore, it can only be used in small amounts through microinjection into the 
cytoplasm as shown by Schmit & Lambert (1990). However, it was reported that cells 
treated with phalloidin suffer from toxic side effects and show alterations in actin 
distribution and cell motility (Cooper 1987, Wehland et al. 1977). Furthermore, to date 
it is not possible to chemically synthesize phalloidin, which instead needs an elaborate 
isolation procedure from the mushroom itself. 
 
Commonly used in live cell analysis is actin itself, genetically coupled to fluorophores, 
like the green fluorescent protein (GFP; Flynn et al. 2009, Endlich et al. 2007). 
Although this probe displays good labelling of the cytoskeleton, it also has several 
drawbacks: all documented actin fusion proteins exhibit reduced functionality and can 
only be used in the presence of a large pool of non-labelled actin (Yamada et al. 2005). 
Furthermore, actin-GFP exhibits a relatively strong background staining because of 
labelled actin monomers so that the expression level has to be low. Moreover, it was 
shown to affect actin dynamics in vivo (Feng et al. 2005). 
 
Alternatively, several actin-binding-proteins or -domains have been used in the last 
years for visualization of the actin cytoskeleton including moesin in the fruit fly 
Drosophila melanogaster (Edwards et al. 1997), LimE in the slime mold Dictyostelium 
discoideum (Bretschneider et al. 2004), ABP120 in D. discoideum and mammalian cells 
(Pang et al. 1998; Lenart et al. 2005) as well as the recently described utrophin in the 
frog Xenopus laevis (Burkel et al. 2007). The actin cytoskeleton of the budding yeast 
Saccharomyces cerevisiae was successfully labelled using the actin-binding protein Abp140 
(Yang & Pon 2002). In plants, fusions to the actin binding domains of mouse talin or 
fimbrin have been used but each seems to stain only a subset of actin structures and 
can lead to artificial bundling of actin filaments if expressed at high levels (Holweg 
2007, Sheahan et al. 2004).  
In general, all these fusion proteins are still quite large and – while not causing strong 
defects – may subtly influence actin dynamics as they are competing with their 
endogenous counterparts or may modify actin filament stability. Moreover, the usage 
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of these probes has been restricted to a limited range of organisms and generally to 
cells which can be transfected or injected.  
 
2.6 Abp140 as actin probe in Saccharomyces cerevisiae 
 
The actin-binding protein 140 (Abp140) in the yeast Saccharomyces cerevisiae is a 71kDa 
protein consisting of 628 aa and was first identified in 1998 (Asakura et al. 1998). It is 
composed of two open reading frames (ORF; YOR239W and YOR240W) which are 
separated by a +1 translational frameshift and thus, only when a ribosomal error 
occurs, the full-length protein can be translated (Figure 2.7; Asakura et al. 1998). The 
C-terminal ORF shows sequence homologies to S-adenosyl-methionine dependent 
methyltransferases (Katz et al. 2003). In in vitro assays with the recombinant full-length 
protein a bundling activity was reported by Asakura et al.. The deletion of Abp140 has 
no severe phenotype except of a slight delay in polarization and decreased actin speed 
(Riedl 2007). To date, the cellular function of Abp140 remains to be elucidated.  
 
 
 
Figure 2.7 Schematic image of Abp140p in Saccharomyces cerevisiae. The first 17 aa 
compose the actin-binding domain (ABD) of Abp140 and belong to the ORF YOR239W 
whose function is still unknown. The C-terminal ORF YOR240W has a strong sequence 
homology to SAM-methyltransferases but such a function was yet not proven (Katz et al. 
2003). In between the two ORFs a +1 translational frameshift was discovered (Asakura et al. 
1998). 
 
 
Due to its localization to F-actin structures in yeast (cables and patches) as well as co-
localization with phalloidin (Figure 2.8), Abp140 was used as a marker for the 
visualization of actin cables (Fehrenbacher et al. 2004; Yang & Pon 2002). Moreover, 
it is the best live marker so far, because all other described GFP-fusions exclusively 
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label patches (Humphries et al. 2002). During my diploma thesis I demonstrated that 
the first 17 aa comprise the actin-binding domain. I subsequently used this peptide, 
named Lifeact, for imaging the actin cytoskeleton in yeast cells. To date, it is the 
shortest actin marker described (Riedl 2007). Interestingly, there is no homologous 
sequence to Lifeact found in higher eukaryotes. 
 
 
 
Figure 2.8 Colocalization of GFP-tagged Abp140p and Rhodamine-phalloidin. Yeast 
cells were transformed with a plasmid encoding for Abp140p fused to GFP (a), fixed and 
stained with Rhodamine-phalloidin (b) for F-actin structures. A perfect overlap can be 
observed. Scale bar: 1.5 µm  
Source Image: Yang & Pon, 2002 
 
 
2.7 Transgenic mice 
 
Transfection of cell lines or primary cells is a standard technique in cell biological 
research. However, there are several limitations to this approach as several cell types 
cannot be transfected, such as platelets, or are difficult to transfect such as neutrophils 
and naïve lymphocytes. In addition, questions of multi-cellular organization such as 
organogenesis or embryo development cannot be addressed in cell culture systems. 
Finally, many disease models and medical applications rely on the use of animals – 
mostly mouse models. To address those issues, particularly regarding the actin 
cytoskeleton, it is of great benefit to have access to transgenic mice expressing a 
marker for F-actin.  
To date, there are two standard approaches for generating genetically modified mice: 
either by homologous recombination or by random integration of the gene of interest. 
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The former is used for the generation of knock-out or knock-in mice where the 
accurate replacement of an existing gene is favoured. Thereby stably transfected 
embryonic stem cells are inserted into wildtype blastocysts. Then, the resulting 
chimeric mice have to be backcrossed to obtain ubiquitous expression or deletion of 
the gene of interest (Hooper et al. 1987). In that case, where the integration locus is 
not so important many researchers take advantage of the second approach. The 
engineered DNA is injected into fertilized oocytes which are implanted into 
pseudopregnant mice. Then, a portion of the offspring shows random integration of 
the DNA into the genome, the so-called transgenic mice (Page et al. 1995; Co et al. 
2000). This approach is less time-consuming compared to the first one but as the 
integration locus is not controlled, it may also lead to the destruction of important 
genes or integration into silenced sites. More recently, a third approach was shown to 
be suitable for the generation of genetically modified mice. This method uses bacterial 
artificial chromosomes (BAC) which also integrate randomly into the genome. BACs 
are capable of holding large DNA sequences (up to 200 kb) and thus, containing 
complete locus control regions instead of the promoter sequence alone (Armstrong et 
al. 2010; Johansson et al. 2010). This is particularly interesting for genes with unknown 
transcriptional control elements because a large part of the genome surrounding the 
gene of interest may be used in that vector probably containing the necessary 
components.  
 
A number of transgenic mice are available to study the actin cytoskeleton, all of which 
express actin itself coupled to GFP. The first GFP-actin transgenic mouse was 
generated with transgene expression from the chicken-β-actin promoter and shows 
fluorescent neurons (Fischer et al. 2000). Another transgenic mouse with expression 
only in keratinocytes was generated by coupling the GFP-actin sequence to the K14 
promoter (Figure 2.9; Vaezi et al. 2002). 
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Figure 2.9 Actin-GFP transgenic mice with keratinocyte-specific promoter. A) The 
construct used for generating GFP-actin mice contains the K14 promoter and the murine ß-
actin gene. B and B’) Newborn transgenic mouse and wildtype littermate imaged with a 
stereomicroscope showing expression of GFP-actin in the skin. C and D) Frozen skin 
sections of a transgenic and a wildtype mouse stained for laminin (red) and DNA (blue) and 
imaged with epifluorescence microscopy. GFP-actin expression can be observed in the skin 
of the transgenic mouse.  
Source: Vaezi et al. 2002 
 
 
In 2007 (Gurniak & Witke) a transgenic mouse was reported with almost ubiquitous 
expression of GFP-actin. These mice were generated by replacing one profilin 1 allele 
with the GFP-actin sequence. Due to this strategy the transgenic mice were 
heterozygous knockouts for profilin 1; however, this did not lead to obvious defects as 
reported previously (Witke et al. 2001). As a consequence, it is impossible to generate 
mice which are homozygous for GFP-actin because profilin 1 null mice are not viable 
anymore (Witke et al. 2001). Furthermore, because profilin 1 is expressed at very low 
levels in skeletal muscle, this tissue was being considered negative for GFP-actin. 
Moreover, this transgenic mouse model has several limitations including a low signal-
to-noise ratio due to the use of GFP-actin (discussed in section 2.5) and in general a 
low fluorescent signal of the marker (personal communications Dr. Michael Sixt, MPI 
Biochemistry and Dr. Frank Bradke, MPI Neurobiology). 
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2.8 Aim of the thesis 
 
An ideal marker for labelling the actin cytoskeleton should have the following 
properties: i) small, ii) cheap and easy to produce, iii) specific actin staining, vi) no 
interference with cellular processes. Established markers for living cells exhibit several 
limitations in use. Fluorescently labelled proteins such as phalloidin are mainly used in 
fixed samples because of difficult handling and exhibiting toxic effects. Genetically 
encoded fusion proteins such as actin itself or actin-binding proteins often show 
reduced functionality and can alter actin dynamics in vivo.  
 
Therefore, in the first part of my Ph.D. thesis, the aim was to characterize and validate 
Lifeact, the recently discovered actin-binding-domain in Abp140p of Saccharomyces 
cerevisae which consists of only 17 aa, as an actin marker for mammalian cells. I 
elucidated the in vitro and in vivo properties of Lifeact providing deep insights into the 
capabilities of Lifeact as novel, versatile marker for F-actin. 
Subject of the second part of my thesis was to provide also a tool for research areas 
where single-cell based assays encounter difficulties such as organogenesis or 
development. Referring to this, I generated transgenic mice ubiquitously expressing 
Lifeact-EGFP or Lifeact-mRFPruby. Furthermore, I characterized the expression of 
the marker on organismic and cellular level qualitatively and quantitatively.   
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3 RESULTS 
 
3.1 Identification of Lifeact in Saccharomyces cerevisiae 
 
During my diploma thesis, I showed that, the first 17 aa of the actin binding protein 
Abp140 (Lifeact; Figure 3.1a) in Saccharomyces cerevisiae are sufficient to bind to F-actin 
(Asakura et al. 1998; Riedl 2007). I subsequently used this small peptide throughout 
my study for labelling actin structures in yeast for live-cell analyses (Figure 3.1b, c). 
Being the shortest actin marker to date, I assumed that this peptide would be a good 
candidate to visualize actin also in other organisms. 
 
b c
a
 
 
Figure 3.1 Abp140p and Lifeact bind to F-actin in yeast. Protein-Alignment of Abp140 
homologes (first N-terminal 17aa) in different fungi (a). Wildtype yeast cells were transformed 
with a vector containing either the full-length gene of Abp140 or the first N-terminal 17aa 
(Lifeact), both tagged to GFP. b) TIRFM image of Abp140GFP distribution in an 
unpolarized yeast cell. c) Distribution of Lifeact-GFP (N-terminal 17aa) in a yeast cell. Scale 
bars: 5µm. 
 
No homologous sequence to the N-terminal part (including Lifeact) of Abp140 was 
found in higher eukaryotes (fungi and higher kingdoms). Moreover, only in very 
closely related species of Saccharomyces cerevisiae, namely the family of 
Saccharomycetaceae, were homologous sequences found as depicted in Figure 3.2. In 
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this family, the sequence of the first 17 aa was highly conserved suggesting that it 
represents the actin-binding domain in these proteins (Figure 3.1a). 
Eucaryota
Opisthokonta
Dikarya
Amoebozoa
Fungi Metazoa
Saccharomycetaceae
0.1 substitutions/site
 
Figure 3.2 From eukaryotes to yeasts. Partial phylogenetic tree from eukaryotes to fungi 
adapted from Fitzpatrick et al. (2006). This fungal supertree was generated using a 
concatenated alignment of 153 universally distributed fungal genes to identify the 
relationships. Bootstrap scores for all nodes are displayed. All members of the family 
Saccharomycetaceae (green box) showed similar sequences to Abp140 of S. cerevisiae. No 
similar proteins could be found in the rest of the kingdom of fungi (model organisms 
highlighted with orange boxes) and all other eukaryotes. 
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Despite being a member of the Saccharomycotina, the human pathogenic Candida albicans, 
did not show sequence similarity with Abp140. Hence, it was not surprising that, also 
more distantly related fungi such as the model organisms Neurospora crassa, 
Schizosaccharomyces pombe and Ustilago maydis did not show conservation of this protein 
(Figure 3.2). 
Based on these observations, I analyzed Lifeact regarding its ability and properties as 
an actin marker in mammalian cells. First of all, analyses of effects on actin kinetics by 
Lifeact were performed using biochemical approaches described in the following 
section. 
 
3.2 Biochemical properties of the Lifeact peptide 
 
For the in vitro characterization experiments, an in-house peptide synthesis service to 
chemically synthesize a version of Lifeact, either unmodified or N-terminally coupled 
to FITC (Fluorescein-5-isothiocyanat; F-Lifeact) was used.  
 
To determine the affinity of F-Lifeact to filamentous actin the dissociation 
constant (Kd) was measured by co-sedimentation in the absence (2.2±0.3 µM, Figure 
3.3a) and presence of 100nM phalloidin (2.0±0.4 µM). Because the binding affinity 
was not significantly altered, I suggested no competing effects on F-actin with F-
Lifeact and phalloidin. Then, F-Lifeact binding to G-actin was monitored by 
fluorescence enhancement of pyrene-labelled actin and a 30-fold higher Kd of 70±25 
nM (Figure 3.3b) was found. The affinities to G- and F-actin were confirmed using 
anisotropy (280±100 nM G- vs. 2.3±0.9 µM F-actin, Figure 3.3c) and fluorescence 
enhancement (40±10 nM G- vs. 1.3±0.5 µM F-actin, Figure 3.3d) of the FITC moiety 
on F-Lifeact. Addition of the G-actin sequestering factors profilin or Latrunculin A 
did not perturb F-Lifeact binding to G-actin (Kd of 40±10 nM for both, Figure 3.3b) 
indicating non-overlapping binding sites on actin. Next, the influence of F-Lifeact on 
polymerization and depolymerization of pyrene labelled actin was tested (Cooper et al. 
1983). Nucleation and elongation phases of actin polymerization were not affected by 
F-Lifeact concentrations up to 55 µM (Figure 3.3e). Likewise, depolymerization rates 
Results 
 
 - 32 - 
were not different from controls using both low (1.1 µM) or high (55 µM) 
concentrations of F-Lifeact (Figure 3.3f).  
 
 
 
Figure 3.3 Actin binding and polymerization. (a) F-Lifeact binding to rabbit muscle F-
actin. The ratio of bound vs. total fluorescence of peptide co-sedimented with various 
concentrations of F-actin is shown. (b) F-Lifeact binding to G-actin. The increase in pyrene-
labelled G-actin fluorescence in the presence of varying amounts of F-Lifeact is shown. 
Fluorescence was normalized to maximum values. (c, d) Measurement of F-Lifeact binding to 
G-actin (filled black squares) and F-actin (open grey circles) by monitoring (c) changes in the 
anisotropy of the FITC moiety. Values were normalized to the maximum anisotropy 
observed. Solid lines: fits to the quadratic expansion of the binding polynomial (see methods) 
and (d) fluorescence enhancement of FITC. The fluorescence was normalized to the 
maximum observed. Solid lines: fits to the hyperbolic binding isotherm. (e) Actin 
polymerization assay. Polymerization of 20% pyrene-labelled actin was followed in the 
presence of indicated concentrations of F-Lifeact. (f) Actin depolymerization assay. 
Depolymerization of 100% pyrene-labelled F-actin was followed after dilution below 200 nM 
with the indicated concentrations of F-Lifeact.  
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To test for competition of F-Lifeact with actin side binding proteins, myosin II and α-
actinin were co-pelleted with F-actin at different F-Lifeact concentrations (0, 1, 10 and 
50 µM) and I found that both interactions remained unaffected (Figure 3.4a, b). To 
obtain an estimation of the structure of Lifeact circular dichroism (CD) spectroscopy 
and nuclear magnetic resonance (NMR) were employed. As a result, Lifeact formed a 
nascent helix in water that could be further stabilized by alcohol addition to a typical 
α-helix ranging from residues 2-10 (Figure 3.4c, d). These structural features were 
reminiscent of the G-actin binding peptide thymosin β4 (Czisch et al. 1993). 
 
 
 
Figure 3.4 Side binding of actin and Lifeact structure. (a, b) SDS PAGE of pellet (P) and 
supernatant (S) fractions of F-actin sedimented with myosin (a) and α-actinin (b) in the 
absence and presence of F-Lifeact. Arrowheads indicate positions of myosin light chains. (c) 
Circular Dichroism (CD) measurements on F-Lifeact upon titration with 0-50% 
trifluorethanol (TFE). Inset: CD on F-Lifeact (in PBS) and Lifeact (in 10% acetic acid, pH 3) 
without TFE. (d) Short and medium range NOE connectivities involving the NH and C
α
H 
protons. Blue bars represent measurements on F-Lifeact at pH 7.1, red bars represent 2D 
NOESY NMR spectra of Lifeact at pH 3.0 in the presence of 15% (v/v) HFP-d
2
. 
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3.3 Expression of Lifeact in mammalian cells 
 
The results of sections 3.1 and 3.2, demonstrating that Lifeact is suitable for actin 
labelling in budding yeast and non-interfering with actin kinetics in vitro, indicated that 
Lifeact could also be an eligible live-cell marker for actin in other organisms. To test 
the utility of Lifeact in mammalian cells, two constructs were generated for transient 
and stable expression in cells. The plasmids pLifeact-EGFP and pLifeact-mRFPruby 
(Fischer et al. 2006) were based on the pEGFP-N1 backbone from Clontech 
(Clontech-Takara Bio Europe, France). Expression in this vector is driven by the 
cytomegalovirus (CMV) promoter sequence. 
As the first step, I transiently transfected the EGFP-containing construct into 
immortalized mouse embryonic fibroblasts (MEF). They were plated on glass-bottom 
dishes and imaged by total internal reflection fluorescence microscopy (TIRFM) which 
allowed high contrast visualization of the cortical actin cytoskeleton. I found specific 
labelling of F-actin structures in this cell type (Figure 3.5a). Stress fibers were 
prominent on the ventral, adhesive side of tightly adherent fibroblasts. A highly 
dynamic, lamellipodial network of filaments was observed at the cell periphery where 
also many motile filopodia appeared (Figure 3.5b).  
 
 
 
Figure 3.5 Lifeact stained F-actin structures in MEFs. a) Schematic image of a fibroblast 
showing F-actin structures present in this cell type, such as stress fibers, cortical actin and 
filopodia. b) Mouse embryonic fibroblasts were transiently transfected with Lifeact-EGFP 
and imaged with TIRFM. Scale bar: 5µm. 
 
Source Image a): Molecular Biology of the Cell 2002 
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In addition, the signal-to-noise ratio was high. However, the promoter used in our 
constructs provided variable expression levels and upon very high expression of 
Lifeact, I could observe aberrantly bundled actin and reduction of actin dynamics. 
I then analyzed Lifeact expression in a variety of cell types covering most of the 
primary body tissues – except for muscle tissue - including primary rat hippocampal 
neurons (nervous), Madin-Darby canine kidney (MDCK) cells (epithelial) and 
dendritic cells (hematopoietic) (Figure 3.6a-c). I again used TIRF microscopy to 
visualize the cortical actin with high contrast and temporal resolution to be able to 
observe even slight changes in actin dynamics or organization. 
 
 
 
Figure 3.6 Lifeact-EGFP expression in different cell types. Lifeact-EGFP was transiently 
expressed in primary rat hippocampal neurons (a), MDCK cells (b) and primary mouse 
dendritic cells (c) and imaged with TIRFM. All scale bars: 5µm. 
 
Analysis of the actin cytoskeleton of the above mentioned cell types revealed no 
differences to previously reported actin structures. Stably transfected MDCK cells 
showed stress fibres (Figure 3.6b) and circumferential actin belts at the cell periphery 
(Abe & Takeichi 2008; Martin et al. 2009).  
 
I used neurons isolated from rat hippocampi because these cells show very unique F-
actin structures and are sensitive to disturbing effects (Sarmiere & Bamburg 2004; 
Bentley & Toroian-Raymond 1986). Dynamic lamellipodial actin in growth cones 
(Figure 3.7a), an isotropic network of actin filaments on the cortex of the cell bodies 
(Figure 3.7b) and highly dynamic filopodia that frequently underwent kinking and 
torsion (Figure 3.7c) were typical structures observed (Pak et al. 2008). 
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Figure 3.7 Primary hippocampal neurons expressing Lifeact-EGFP. Primary neurons 
were prepared from rat hippocampi and transfected with Lifeact-EGFP and imaged with 
TIRFM. a) Actin distribution in growth cone of polarizing neuron. b) Cortical actin network 
of a hippocampal neuron. c) Time series of filopodial dynamics. Scale bars: 5 µm (a,c), 1µm 
(b); Time in seconds (c). 
 
In addition, I transiently transfected bone-marrow derived mouse dendritic cells and 
performed a 2D-under-agarose assay (Heit & Kubes 2003) and imaged cells migrating 
towards a gradient of CCL19 (Figure 3.8). These cells showed a highly dynamic 
lamellipodial actin at the cell periphery but no stable bundles in the cell body as 
described previously for migrating cells (Le Clainche & Carlier 2008; Renkawitz et al. 
2009).  
 
 
 
Figure 3.8 Lifeact stained F-actin in dendritic cells. Primary dendritic cells were 
transfected with Lifeact-EGFP. A 2D-under-agarose assay was performed with CCL19 
present. Time series of a migrating dendritic cell imaged with TIRFM. Scale bar: 5µm, Time in 
seconds. 
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To observe whether Lifeact could stain the dense and highly structured contractile 
ring established during mitosis to enable separation of the daughter cells, I performed 
long-term imaging of stably expressing MDCK cells. I found that, during cytokinesis, 
Lifeact-EGFP highlighted the contractile ring of these cells, as depicted in Figure 3.9, 
suggesting non-overlapping binding sites on actin of Lifeact and the cytokinesis-
involved proteins. 
 
0 2 4 6 8 10 12 14 16 18
 
 
Figure 3.9 Lifeact stained the contractile ring during cytokinesis. MDCK cells 
expressing Lifeact-EGFP were imaged in a climate-controlled epifluorescence microscope for 
more than 12 hours. Time-series of a cell undergoing cytokinesis is depicted. Scale bar: 5µm; 
Time in minutes. 
 
In conclusion, I found that Lifeact specifically stained all known F-actin structures in 
different mammalian cell types with no severe physiological effects and thus, showed 
its applicability as live-cell marker. However, to support this finding, it was necessary 
to compare Lifeact with previously established markers for labelling of the actin 
cytoskeleton in mammalian cells (Section 3.5). 
 
3.4 Comparison of Lifeact with other F-actin markers 
 
To compare Lifeact to established F-actin markers, I transfected MEFs with either 
Lifeact-EGFP, EGFP-actin (Ballestrem et al. 1998) or EGFP-Utrophin (Burkel et al. 
2007) expressed under the CMV promoter. Qualitative examination of transfected 
cells by widefield fluorescence microscopy revealed that, labelling of the actin 
cytoskeleton was comparable with all three probes (Figure 3.10).  
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Figure 3.10 Comparison of Lifeact-EGFP with EGFP-actin and utrophin-EGFP 
staining. MEFs were transfected with either Lifeact-EGFP (middle) or EGFP-actin (left) or 
utrophin-EGFP (right) and the actin cytoskeleton was visualized using epifluorescence 
microscopy. Scale bar: 5 µm 
 
To directly compare the F-actin labelling quality of Lifeact, I used either fixed MEFs, 
transiently expressing Lifeact-EGFP, and co-stained those cells with rhodamine-
phalloidin or living MDCK cells co-transfected with Lifeact-EGFP and mRFPruby-
actin (or Lifeact-mRFPruby and EGFP-actin). Microscopic analysis of cells positive 
for both markers revealed a perfect co-localization of Lifeact with either phalloidin or 
mRFPruby-actin, respectively (Figure 3.11a, b). In general, I found that Lifeact 
exhibited a lower background signal and therefore better signal-to-noise ratio 
compared to mRFPruby-actin or EGFP-actin. 
 
In conclusion, these results demonstrated that Lifeact specifically labels filamentous 
actin in mammalian cells in a comparable quality to the marker used in fixed samples, 
phalloidin. Notably, I could show that Lifeact labels F-actin in higher grade compared 
to established markers such as actin coupled to a fluorescent protein.  
 
However, to further test the suitability of Lifeact as a better alternative to established 
markers, I was prompted to analyze whether cells expressing Lifeact are affected in 
cytoskeletal dynamics. 
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Figure 3.11 Lifeact co-localized with phalloidin and mRFPruby-actin. a) MEFs were 
transfected with Lifeact-EGFP, fixed and co-stained with rhodamine-phalloidin and imaged 
by confocal microscopy. b) MDCK cells were co-transfected with Lifeact-EGFP and 
mRFPruby-actin and imaged by TIRFM. Scale bars: 5µm. 
 
 
3.5 Cytoskeletal functions are not compromised by expression 
of Lifeact in mammalian cells 
 
The findings in the previous chapters demonstrated that Lifeact could indeed be used 
to visualize the actin cytoskeleton in mammalian cells. I now wanted to test, whether 
Lifeact expression leads to measurable changes in actin dynamics in transfected cells. 
To this end, I studied three parameters that are dependent on a functional actin 
cytoskeleton: cell polarization, retrograde actin flow in lamellipodia and directed cell 
migration.  
Neuronal polarization is essential for development and functionality of these cells. To 
determine and establish one axon out of all dendrites is strongly dependent on a 
dynamic actin cytoskeleton (Witte & Bradke 2008). To examine possible neuronal 
polarization defects, primary neurons were prepared from rat hippocampi, transfected 
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with either Lifeact-EGFP or EGFP-actin and cultured for three days before fixation 
and staining for Tau-1. This protein is only present in the mature axon and therefore 
was used as characteristical marker. These two samples as well as mock transfected 
control cells were subsequently analyzed for their polarization stage. Cells were 
categorized as either having no axon, one axon or more than one axon. I found that 
neuronal polarization was not significantly affected by the expression of Lifeact-EGFP 
(Fig. 3.12, 60.1±0.2 % cells formed one axon compared to 68.5±8.7 % of mock 
transfected cells) but a comparable expression of EGFP-actin led to a significant 
alteration in the polarization stages (52.3±4.4 %, ANOVA: F2,8 = 6.205, P < 0.0346; 
post-hoc Dunnett's test: P > 0.05 for Lifeact-EGFP, P < 0.05 for EGFP-actin). 
Hence, these results indicated that Lifeact expression does not affect neuronal 
polarization. In contrast, EGFP-actin expression led to impairments in performing 
this process. 
 
Lifeact-EGFP EGFP-actincontrol
 
 
Figure 3.12 Quantification of neuronal polarization. Primary rat hippocampal neurons 
were transfected with either Lifeact-EGFP or EGFP-actin and cultured for three days. Then, 
they were analyzed for the presence of axons in comparison to mock transfected cells. Data 
shown are averages ± SD from at least three experiments. 
 
I next measured the speed of retrograde actin flow in lamellipodia of MEFs. In 
lamellipodia actin forms a highly dynamic network of branched filaments (Chhabra & 
Higgs 2007). During treadmilling, these filaments move from the cell periphery in 
direction to the cell body and this movement is called retrograde flow. The speed of 
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this process is dependent on the actin kinetics in vivo and hence, slight changes can 
directly be observed by its measurement (Lin & Forscher 1995, Medeiros et al. 2006). 
To this end, I transfected MEFs with either Lifeact-EGFP or EGFP-actin and imaged 
the cells with TIRFM. As a control, I used untransfected cells which were imaged by 
differential interference contrast (DIC). Using this method, I monitored the retrograde 
membrane flow which corresponds to the retrograde actin flow in cells and thus, 
provided a tool for measuring the speed in non-manipulated cells. The analysis of the 
speed of retrograde flow in lamellipodia revealed that Lifeact-EGFP transfected 
fibroblasts were indistinguishable from non-transfected cells at 4 µm/min whereas the 
retrograde flow was reduced to about half in EGFP-actin expressing cells (Fig. 3.13; 
ANOVA: F2,134 = 53.39, P < 0.0001; post-hoc Dunnett's test: P > 0.05 for Lifeact-
EGFP, P < 0.05 for EGFP-actin). These results supported the previous finding that 
EGFP-actin disturbs actin kinetics and clearly demonstrated that Lifeact does not 
interfere with retrograde actin flow. 
 
****
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Figure 3.12 Quantification of the speed of lamellipodial retrograde actin flow. MEFs 
were transfected with either Lifeact-EGFP or EGFP-actin and imaged by TIRFM. Untreated 
control cells were imaged by DIC. The velocity of the retrograde flow was measured from 
kymograph traces. P > 0.05 (*) for Lifeact-GFP, P < 0.05 (***) for EGFP-actin. Data shown 
are averages +/- SD from at least three experiments. 
 
Finally, I examined the chemotactic speed of dendritic cells. These cells are mediators 
of the adaptive immune response while presenting antigens to lymphocytes. They 
recognize invaders in the periphery of an organism, e.g. the skin. After engulfing the 
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invaded particles, they migrate towards the draining lymph node, along a chemokine 
gradient (CCL19 or CCL21), where they activate lymphocytes (Montoya et al. 2002).  
First, bone marrow precursors were matured to dendritic cells and transfected with 
either Lifeact-EGFP or EGFP-actin. After sorting positive cells by FACS, they were 
embedded in a three-dimensional collagen-matrix (Lammermann et al. 2008). Video-
microscopy was performed to follow migration of these cells towards a chemokine 
(CCL19; Figure 3.13a). The speed of single cells was compared to non-transfected 
control cells. Lifeact-EGFP expression had no significant effect on the speed of 
chemotactic dendritic cell migration (paired t-test (two-tailed), P = 0.40, n = 3 
experiments, 837 tracked cells), while EGFP-actin expressing cells migrated slower 
than control cells (P = 0.04, n = 4 experiments, 689 tracked cells) (Figure 3.13b).  
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Figure 3.13 Comparison of chemotactic speed of dendritic cells. a) Schematic drawing of 
experimental setup: primary dendritic cells were embedded in a three-dimensional collagen gel 
and a solution of the chemokine CCL19 was applied to the top of the matrix. Migration was 
monitored by video-microscopy and migrating cells were tracked using Metamorph software 
(Molecular devices). b) The chemotactic speed of transiently transfected dendritic cells relative 
to untransfected cells is shown. P = 0.40 (*) for Lifeact-EGFP, P = 0.04 (***) for EGFP-
actin. Data are averages ± SD from at least three experiments. 
 
Taken together, expression of Lifeact in mammalian cells did not lead to significant 
changes in actin dynamics during neuronal polarization, lamellipodial retrograde actin 
flow and speed of chemotactic dendritic cells. However, EGFP-actin expression 
significantly altered actin dynamics in these processes. 
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3.6 Labelling mammalian cells and tissues using FITC-Lifeact 
 
The findings described above clearly demonstrated the utility of Lifeact, expressed as 
fusion protein, for staining of actin structures in living mammalian cells. Since the 
17aa long Lifeact peptide (F-Lifeact) was easy to produce synthetically (see section 
3.2), I addressed the question whether this peptide would also be usable as cellular 
actin marker.  
To analyze F-Lifeact in fixed cells and tissues, I used fixed MDCK cells, stained these 
with the F-Lifeact and directly compared it with the commonly used F-actin probe 
phalloidin coupled to the red dye Cy3. Using TIRF microscopy I observed nearly 
complete overlap of the two markers on actin structures of the dorsal (Fig. 3.14 a) and 
ventral surface.  
 
 
 
Figure 3.14 FITC-Lifeact stained actin in fixed samples. a) MDCK cells were fixed in 
and stained with F-Lifeact (green) and Cy3-phalloidin (red; overlay in yellow). TIRFM images 
of the dorsal site are depicted. b) Cryosections of mouse femur skeletal muscle were fixed and 
stained with F-Lifeact (green) and Cy3-phalloidin (red; overlay in yellow) and imaged with 
confocal microscopy. Scale bars: 5 µm. 
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Furthermore, I prepared cryosections of heart and femur skeletal muscle from mice 
and stained the fixed samples with F-Lifeact and Cy3-phalloidin. Examination of the 
samples with confocal microscopy again revealed extensive overlap of the actin probes 
in the expected banded pattern (Fig. 3.14 b, Molecular Biology of the Cell, 2002).  
These findings demonstrated that the F-Lifeact peptide can be used as a non-toxic 
alternative to phalloidin. This is particularly useful as the latter is a bicyclic 
heptapeptide, which is difficult to synthesize on large scale (Wieland et al. 1983). 
 
As the binding strength of F-Lifeact to filamentous actin was very low in vitro (see 
section 3.2 Figure 3.3a), I tested the staining persistence in wash-out experiments. I 
could not detect any decrease in staining even after repeated washing (not shown). 
Surprisingly, F-Lifeact rapidly exchanged on F-actin as observed by fluorescence 
recovery after photobleaching (FRAP; Fig. 3.15b) suggesting that the robust labelling 
with F-Lifeact was due to the cell membrane which was too dense to release the 
peptide. Also consistent with these results, Lifeact-EGFP, transiently transfected into 
MEFs, recovered rapidly as evaluated by FRAP analysis (Figure 3.15 a). 
 
 
 
Figure 3.15 FRAP of Lifeact in living and fixed fibroblasts. a) FRAP in MEF transfected 
with Lifeact-EGFP. Numbers in insets (magnification of the boxed area) indicate time relative 
to bleaching in seconds. b) FRAP of a 4%-paraformaldehyde-fixed MEF stained with F-
Lifeact. Numbers in insets (magnification of the boxed areas) indicate time relative to 
bleaching in seconds. 
 
Based on these encouraging findings, I suggested that F-Lifeact could also be used as 
an F-actin marker in living cells. To test this hypothesis, I used the “scrape-loading”-
technique which allows diffusion of a peptide into the cytoplasm through transient 
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membrane pores caused by mechanical removal of adherent cells from a surface 
(McNeil et al. 1984). Fibroblasts or MDCK cells were scrape-loaded with F-Lifeact 
present and replated on fibronectin-coated dishes to allow fast adhesion and 
subsequent imaging of the cells. To avoid artefacts due to membrane damage after 
scrape loading or excessive loading of cells with peptide I focused on weakly labelled 
cells. Microscopic analysis with TIRF revealed typical staining of F-actin in stress 
fibres and lamellipodia (Fig. 3.16a, b). I also performed long-term imaging (up to 12 
hours) to analyze the persistence of the staining and found that the fluorescence signal 
was maintained over a period of 4-6 hours. This short time could be due to the 
degradation of the peptide, to fluorochrome fading or both. 
 
 
 
Figure 3.16 FITC-Lifeact stained F-actin in living fibroblasts. MEFs were scrape-loaded 
with F-Lifeact present and replated on fibronectin-coated glass-bottom dishes. Using TIRFM 
spreading of the cells (a) and subsequent building of stress fibers (b) could be observed. Scale 
bars: 5µm, Time in seconds. 
 
Previously reported data showed that primary neutrophils could also be loaded with 
small peptides (McNeil et al. 1984). I therefore wanted to test whether F-Lifeact is 
suitable for labelling F-actin in these cells via “scrape-loading”.  
Neutrophils represent key players of the innate immune response and serve as model 
system for the study of cell polarization (Weiner 2002; Nathan 2006). The rapid 
polymerization of actin filaments is fundamental to neutrophil effector functions, e.g. 
extravasation, chemotaxis or phagocytosis. Since neutrophils are terminally 
differentiated and therefore non-transfectable, the current knowledge about neutrophil 
actin reorganization in response to chemotactic stimuli is mainly based on studies 
using HL-60 cells, a myeloid tumour cell line which can be differentiated into 
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neutrophil-like cells (Weiner et al. 1999). Furthermore, integrin dependent cytoskeletal 
reorganization in response to immune complexes (IC) has only been studied on fixed 
cells using fluorescent phalloidin reagents (Tang et al. 1997). With F-Lifeact it could be 
possible to examine this process in living cells. 
 
To this end, freshly isolated human primary neutrophils were plated on a cell culture 
dish in medium containing 0.5% bovine serum albumin (BSA) allowing only slight 
adherence to the surface. This was a critical step because once these cells get activated 
they irreversibly and strongly adhere to a surface and scraping them off leads to 
complete destruction. Hence, with this approach it was possible to scrape the cells off 
the surface without severely damaging them but yet sufficiently so that they take up 
the F-Lifeact peptide.  
 
Notably, for the first time I could follow the rapid dynamics of actin in these cells 
during spreading on ICs and during spontaneous migration. To validate the new probe 
I analyzed F-Lifeact-loaded neutrophils during spreading on ICs. Using TIRFM I 
observed two F-actin structures in the spreading cells. Peripheral areas spread out 
rapidly with a speed of 14.1±2.8 µm/min (n=10) while there were no signs of 
retrograde actin transport (Figure 3.17 a, c). In central areas stationary patches formed 
that rapidly extended into the periphery after cells stopped spreading (Figure 3.17b, d).  
 
In conclusion, these results demonstrated that F-Lifeact is suitable for labelling of 
filamentous actin in fixed samples alternatively to phalloidin with the advantages of 
being non-toxic and easy to produce. Moreover, the actin cytoskeleton of living cells 
which are hard to transfect or even non-transfectable like primary neutrophils could 
also be labelled using F-Lifeact. However, to prevent artefacts by damaging the cells 
using scrape-loading, it would be advantageous to find other methods for transferring 
F-Lifeact into cells in future studies. 
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Figure 3.17 FITC-Lifeact staining in living primary neutrophils. Primary neutrophils 
isolated from human blood were scrape-loaded with F-Lifeact, replated and cell spreading was 
visualized with TIRF microscopy. (a, b) Time series of neutrophil spreading on immune 
complexes. c) and d) kymographs of the indicated regions in (a) and (b), respectively. Scale 
bars, 5 µm; Time in seconds. 
 
In summary, in the first part of my work I characterized the newly discovered actin-
binding domain of the yeast Abp140, named Lifeact, as a marker for F-actin in 
mammalian cells. Lifeact showed low binding affinity to F-actin in vitro and did not 
interfere with actin kinetics as shown with biochemical approaches. Moreover, its 
binding did not compete with major actin-binding proteins. Furthermore, I 
demonstrated that primary cells and cell lines expressing Lifeact exhibited specific and 
bright labelling of their actin cytoskeleton. This could also be achieved by using 
chemically synthesized F-Lifeact in fixed samples as well as in cell lines and non-
transfectable cells. Most importantly, I showed that, in contrast to EGFP-actin, Lifeact 
expression did not affect actin dynamics and sensitive morphogenetic functions. I 
therefore suggest that Lifeact can be considered as an F-actin marker superior to 
established markers. 
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3.7 Generation of Lifeact-transgenic mice 
 
Although I could show in the previous sections that Lifeact is suitable as actin marker, 
there are limitations to its usage in single-cell analyses. When focusing on multi-
cellular processes such as organogenesis or embryogenesis, to date it is not possible to 
address these with cell-culture systems. Moreover, several research areas such as 
disease models or medical applications depend on the usage of animals, mainly mice. 
Therefore, I decided to generate transgenic mice either with Lifeact-EGFP or Lifeact-
mRFPruby to provide a unique tool ubiquitously expressing the marker and enabling 
research on tissue and organismic level. Furthermore, Lifeact mice would also be a 
source for pre-stained cells which can be isolated thereby avoiding artefacts produced 
by methods such as injection, transfection or scrape-loading. 
To obtain a broad expression pattern, I used a construct based on the pCAGGS 
vector and inserted either the Lifeact-EGFP or Lifeact-mRFPruby sequence (Figure 
3.18; Niwa et al. 1991). This vector contained the well characterized CMV immediate 
early enhancer, the chicken-β-actin promoter and a chimeric intron and was expected 
to be transcribed in most tissues on high level. The linearized construct was 
microinjected into fertilized oocytes (from C57BL6/N x FVB/N (F2) mice) which 
were immediately transferred into pseudopregnant mice. The offspring were then 
genotyped by PCR to identify transgene insertion into the genome. 
 
 
 
Figure 3.18 Construct generated for pronuclear injection. After linearization of the vector 
the indicated fragment containing Lifeact-EGFP or –mRFPruby was purified and used for 
injection. The sequence contains the chicken beta-actin promoter coupled to a CMV enhancer 
and intron (promoter, dark grey) upstream of the Lifeact-EGFP or -mRFPruby sequence 
(purple-green/red) as well as a Poly-A sequence (light grey). 
 
Nearly 40% of the Lifeact-EGFP and 30% of the Lifeact-mRFPruby mice had 
integrated the transgene. To investigate whether germline transmission of the 
transgenes has occurred, 25 (Lifeact-EGFP) and 28 (Lifeact-mRFPruby) putative 
founders were mated with wildtype (C57/Bl6) mice. The offspring was then either 
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directly tested for a fluorescent signal using a UV-handlamp (Lifeact-EGFP) or by 
microscopic analysis of a tail piece (Lifeact-mRFPruby). I obtained 8 positive founders 
(F0 Generation) for Lifeact-EGFP and 10 positive founders for Lifeact-mRFPruby. 
All of these mice were viable, phenotypically normal and fertile indicating that Lifeact 
insertion into the genome and expression does not severely intefere with normal 
development. 
I then started an in depth characterization of progeny of all positive founders to 
determine the pattern of actin staining in these mice.  
 
3.8 Characterization of the transgenic founders 
 
First, to characterize the founders of both markers in detail, I addressed the question 
whether different organs showed a fluorescent signal. Therefore, I prepared six organs 
of one positive pup of each founder, including brain, heart, spleen, kidney, liver and 
skeletal muscle from femur, and examined their fluorescence level under a stereo 
microscope. While most mice showed a fluorescent signal in several organs, only one 
founder of each strain showed transgene expression in all tested organs (#8-G and 
#2-R; see tables 3.1 and 3.2). Importantly, all organs were of normal size and shape in 
comparison to organs from wildtype mice. Examples of the best founders are depicted 
in Figure 3.19. 
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Tissue Lifeact-EGFP founder 
 1-G 2-G 3-G 4-G 5-G 6-G 7-G 8-G 
Brain 
Heart 
Spleen 
Kidney 
Liver 
Muscle 
x 
x 
x 
- 
- 
x 
- 
- 
- 
- 
- 
- 
- 
x 
x 
x 
- 
x 
x 
x 
x 
x 
- 
x 
x 
x 
x 
x 
- 
x 
x 
x 
x 
x 
- 
x 
x 
- 
x 
- 
- 
- 
x 
x 
x 
x 
x 
x 
 
Table 3.1 Lifeact-EGFP founders showed variable expression patterns. Indicated organs 
were prepared and imaged under a stereo microscope. x = positive for fluorescent signal, - = 
negative for fluorescent signal. Grey = best founder. 
 
 
 
 
Tissue Lifeact-mRFP founder 
 1-R 2-R 3-R 4-R 5-R 6-R 7-R 8-R 9-R 10-R 
Brain 
Heart 
Spleen 
Kidney 
Liver 
Muscle 
x 
x 
- 
- 
- 
x 
x 
x 
x 
x 
x 
x 
- 
x 
- 
- 
- 
x 
- 
- 
x 
x 
- 
x 
x 
- 
x 
x 
- 
x 
- 
x 
- 
x 
x 
x 
x 
- 
x 
- 
x 
- 
- 
x 
x 
x 
- 
- 
- 
x 
- 
x 
x 
x 
x 
- 
x 
x 
x 
- 
 
Table 3.2 Lifeact-mRFPruby founders showed variable expression patterns. Indicated 
organs were prepared and imaged under a stereo microscopy. x = positive for fluorescent 
signal, - = negative for fluorescent signal. Grey = best founder. 
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Figure 3.19 Lifeact-EGFP and -mRFPruby expression in organs. Heart, brain, skeletal 
muscle from femur, kidney, liver and spleen were isolated from transgenic mice and 
immediately imaged with a stereo microscope. The upper row of each panel shows the results 
from the Lifeact-EGFP founder #8-G, the bottom row shows the results from the Lifeact-
mRFPruby founder #2-R. 
 
Next, I aimed to elicit whether all cells of one cell type express the marker. To this 
end, I performed FACS analysis of blood cells of all Lifeact-EGFP founders. The 
analysis revealed that two transgenic founders (#1-G and 8-G) showed a fluorescent 
signal in approximately 70 % of their blood cells (Figure 3.20) whereas the residual 
founders did not show a fluorescent signal in these cells. Moreover, I could observe by 
flow cytometry that blood cells expressing Lifeact-EGFP showed an up to three times 
log shift in fluorescence signal compared to control cells (Figure 3.20). 
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Figure 3.20 FACS analysis of whole blood cells of Lifeact-EGFP transgenic mice. 
Blood drops were drained into heparin-containing tubes and an erythrocyte lysis step was 
performed. FACS analysis revealed two founders with strong fluorescent signal in ca. 70% of 
blood cells. Plot shows positive transgenic mouse (#8-G) and control littermate. 
 
Next, I wanted to evaluate the tissue expression patterns of Lifeact in more detail. 
Therefore, I prepared cryosections of 14 organs of one pup of each founder and 
imaged them with epifluorescence microscopy. As internal control for actin 
distribution, all sections were counterstained with fluorescently-labelled phalloidin. 
Microscopic analysis of the Lifeact-EGFP founders revealed a perfect colocalization 
of the two markers and still only one founder (#8-G) showed expression in all 
examined tissues (Figures 3.22 and 3.23). All other Lifeact-EGFP founders showed 
variable expression patterns but at least one organ was completely negative for the 
transgene (see table 3.3). The Lifeact-EGFP founder showing expression in all 
examined tissues (#8-G) was used for all further analyses. Table 3.3 depicts all 
examined tissues of all Lifeact-EGFP founders.  
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Tissue Lifeact-EGFP founder 
 1-G 2-G 3-G 4-G 5-G 6-G 7-G 8-G 
Brain 
Heart 
Spleen 
Kidney 
Liver 
Skeletal muscle 
Lymph node 
Genitals 
Small intestine 
Large intestine 
Stomach 
Lung 
Thyroid gland 
Thymus 
x 
x 
(x) 
- 
- 
x 
(x) 
x 
- 
(x) 
x 
- 
(x) 
(x) 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
(x) 
(x) 
(x) 
- 
(x) 
(x) 
(x) 
(x) 
(x) 
(x) 
(x) 
(x) 
(x) 
x 
x 
x 
(x) 
- 
x 
x 
x 
x 
x 
x 
(x) 
(x) 
(x) 
x 
(x) 
(x) 
x 
- 
x 
(x) 
x 
- 
- 
- 
(x) 
(x) 
- 
(x) 
x 
x 
x 
- 
x 
(x) 
(x) 
(x) 
(x) 
- 
(x) 
(x) 
- 
x 
- 
x 
- 
- 
- 
x 
- 
- 
- 
- 
x 
- 
- 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
x 
 
Table 3.3 Examined organs of the Lifeact-EGFP founders. Cryosections of indicated 
organs were made and counterstained with phalloidin. x = positive for actin staining; (x) = 
partially positive staining; - = negative. Grey = best founder. 
 
I also performed the corresponding characterization of tissue sections with all Lifeact-
mRFPruby founders (#1-R – 10-R). In contrast to the Lifeact-EGFP mice, I observed 
bright patches that did not colocalize with phalloidin in seven (#4-R – 10-R) out of 
the ten founders (Figure 3.21). This was probably due to the inherently slow folding 
and high aggregation tendency of all currently available mRFP variants and is typically 
seen when overexpressing RFP-fusion proteins (Mizuno et al. 2001; Baird et al. 2000 
and our own unpublished observation).  
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Figure 3.21 Lifeact-mRFPruby aggregates in transgenic mice. Fixed cryosection of 
thymus of Lifeact-mRFPruby mouse #5-R counterstained with Alexa488-phalloidin. Arrows 
indicate Lifeact-mRFPruby aggregates. Scale bar: 50µm. 
 
Importantly, three founders (#1-R – 3-R) showed no apparent aggregation and the 
fluorescent signal overlapped with phalloidin. One out of these three mice was 
positive in every tested tissue although some tissues, e.g. the liver, showed only partial 
staining (#2-R; Figures 3.24 and 3.25). The most widely expressing Lifeact-mRFPruby 
founder (#2-R) was used for all further analyses. Table 3.4 depicts all examined tissues 
of all Lifeact-mRFPruby founders. 
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Tissue Lifeact-mRFPruby founder 
 1-R 2-R 3-R 4-R   -   10-R 
Brain 
Heart 
Spleen 
Kidney 
Liver 
Skeletal muscle 
Lymph node 
Genitals 
Small intestine 
Large intestine 
Stomach 
Lung 
Thyroid gland 
Thymus 
(x) 
x 
- 
- 
- 
x 
- 
(x) 
(x) 
(x) 
(x) 
(x) 
(x) 
(x) 
x 
x 
x 
x 
(x) 
x 
(x) 
(x) 
x 
(x) 
x 
x 
(x) 
(x) 
- 
(x) 
- 
- 
- 
x 
(x) 
x 
(x) 
(x) 
(x) 
(x) 
(x) 
- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.4 Examined organs of the Lifeact-mRFPruby founders. Cryosections of 
indicated organs were made and counterstained with phalloidin. x = positive for actin 
staining; (x) = partially positive staining; - = negative. Grey = best founder. Founders #4-R to 
10-R showed aggregates. 
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Figure 3.22 Cryosections showing colocalization with phalloidin. Fixed Cryosections of 
indicated tissues of Lifeact-EGFP mice were counterstained with Alexa 560-phalloidin and 
imaged with epifluorescence microscopy. Bright areas in brain section correspond to blood 
vessels which showed very high expression of Lifeact compared to other brain tissues. Scale 
bar: 50 µm. 
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Figure 3.23 Cryosections showing colocalization with phalloidin. Fixed cryosections of 
indicated tissues of Lifeact-EGFP mice were counterstained with Alexa 560-phalloidin and 
imaged with epifluorescence microscopy. Bright areas in spleen and thymus section 
correspond to blood vessels which showed very high expression of Lifeact compared to 
neighboring tissues. Scale bar: 50 µm. 
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Figure 3.24 Cryosections showing colocalization with phalloidin. Fixed cryosections of 
indicated tissues of Lifeact-mRFPruby mice were counterstained with Alexa 488-phalloidin 
and imaged with epifluorescence microscopy. Bright areas in brain section correspond to 
blood vessels which showed very high expression of Lifeact compared to other brain tissues. 
Scale bar: 50 µm. 
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Figure 3.25 Cryosections showing colocalization with phalloidin. Cryosections of 
indicated tissues of Lifeact-mRFPruby mice were fixed and counterstained with Alexa 488-
phalloidin and imaged with epifluorescence microscopy. Bright areas in spleen and thymus 
section correspond to blood vessels which showed very high expression of Lifeact compared 
to neighboring tissues. Scale bar: 50 µm. 
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As the available FACS device did not have a 561 nm Laser, which is necessary for 
excitation of mRFPruby, and appropriate filters for signal detection, I could not 
analyze blood cells of Lifeact-mRFPruby mice with this approach. I therefore directly 
examined isolated blood cells of the three founders #1-R, 2-R and 3-R by 
epifluorescence microscopy. This analysis revealed that only one founder (#2-R) had 
transgene-positive blood cells. 
 
In summary, the generated transgenic mice showed variable expression patterns of 
Lifeact. Positive tissues of all Lifeact-EGFP mice exhibited a bright fluorescent signal 
as well as perfect co-localization with phalloidin. Three Lifeact-mRFPruby founders 
exhibited similar expression patterns while the other founders did not show co-
localization with phalloidin.  One founder of each mouse strain expressed Lifeact in all 
examined tissues (#8-G and #2-R). These lines were used for all further analyses. 
 
 
3.9 Lifeact expression during mouse development 
 
The previous data showed that Lifeact was nearly ubiquitously expressed in adult mice 
of the founders chosen for further study. Next, I wanted to find out if these mice are 
also suitable for developmental research questions and investigated the pattern of 
transgene expression during embryonic development. First, I tested at what time point 
in embryogenesis Lifeact was expressed. To this end, superovulated, transgenic 
females were mated with transgenic males and isolated fertilized oocytes were cultured 
until embryonic day 4.5 (E4.5). Analysis at different stages revealed that very weak 
actin staining was visible in the fertilized oocytes (E0.5; Figure 3.26a). This result was 
in line with previously reported data where the authors did not observe transgene 
expression in oocytes using the same promoter (Niwa et al. 1991). However, the 
fluorescent signal increased after the first division (E1.5; Figure 3.26b). After 48 hours 
and at E4.5 (Figure 3.26c) a very bright signal could be detected by epifluorescence 
microscopy in most cells. In all analyzed embryos (n=15) I observed a mosaic 
expression pattern of Lifeact with weak and strong fluorescent signals (Figure 3.26c). 
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Figure 3.26 Lifeact-EGFP expression in early embryonic stages. Fertilized oocytes were 
isolated from transgenic females mated to transgenic males and cultured till E4.5. a) At E0.5 
and E1.5 cells were imaged by spinning disk microscopy. b) At E4.5 embryos were imaged by 
epifluorescence microscopy. Scale bars: 20µm. 
 
In order to analyze later stages in development, embryos were prepared from pregnant 
mice at E10.5 and E15.5. Expression of Lifeact was ubiquitous and strong although I 
did not verify the expression pattern on cellular level (Figure 3.27).  
 
 
 
Figure 3.27 Lifeact expression in late embryonic stages. Embryos were prepared from 
pregnant wildtype females, mated to transgenic males, at E10.5 and E15.5 and imaged with a 
stereo microscope. Embryos of best Lifeact-EGFP (#8-G; upper panel) and Lifeact-
mRFPruby (#2-R; bottom panel) founders are shown. 
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In summary, Lifeact expression from the chicken-β-actin promoter proved to be 
sufficient to observe and analyze actin structures in early mouse development. Studies 
of actin in oocytes or during oocytes fertilization appear to be limited due to the weak 
signal. Hence, the use of other promoters which lead to higher transgene expression in 
this stage would be required to overcome this problem.  
 
3.10 Lifeact expression and F-actin staining in single cells 
 
Thus far, the results demonstrated that the generated transgenic mice exhibit nearly 
ubiquitous Lifeact expression and specific actin staining. Next, I addressed the 
question whether the actin staining of individual primary cells is sufficiently strong for 
investigation of actin dynamics by live-cell microscopy. Therefore, I isolated different 
cell types including skin fibroblasts, hippocampal neurons and T-lymphocytes and 
imaged them with TIRFM at high time resolution. Strong and specific F-actin staining 
(Figure 3.28) could be observed in all tested cell types as previously described for 
cultured cells (Riedl et al. 2008). Skin fibroblasts showed brightly stained stress fibers 
(Figure 3.28a; Pellegrin & Mellor 2007) and prominent retrograde flow in lamellipodia. 
Also hippocampal neurons showed typical staining of the cortical actin network and 
highly dynamic actin in growth cones (Figure 3.28b and 3.29b; Pak et al. 2008).  
 
 
 
Figure 3.28 Lifeact-EGFP expression in isolated primary cells. Cells were isolated from 
transgenic mice and imaged by TIRFM. Skin fibroblast (a), hippocampal neuron (b) and 
migrating T-lymphocyte (c). Scale bars: 5µm. 
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Activated T-lymphocytes showed a highly dynamic actin network during migration 
with stable, brightly stained patches on the cell body which might represent endocytic 
structures (Figure 3.28c and 3.29a; Stanley et al. 2007). 
 
 
 
Figure 3.29 Actin dynamics in activated, transgenic T-lymphocytes. a) T-lymphocytes 
were isolated from spleen and matured in vitro using ConA and IL-2. During their activated 
state, they were subjected to a 2D-under-agarose assay (Heit & Kubes 2003) and migrating 
cells were imaged by TIRFM. b) Isolated hippocampal neurons were imaged by TIRFM. Time 
series of a growth cone. Time: minutes. Scale bars: 5µm. 
 
Finally, I analyzed F-actin staining in isolated, non-transfectable platelets. FACS 
analysis revealed that nearly 100% of platelets showed a strong fluorescent signal 
(Figure 3.30a). To visualize the actin cytoskeleton, freshly isolated platelets were plated 
on fibrinogen-coated dishes and activated with mouse thrombin. Investigation by 
TIRFM revealed that platelets exhibited bright circumferential actin belts and regular 
arrays of stress fibers (Figure 3.30b; Vidal et al. 2002). 
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Figure 3.30 F-actin staining in isolated platelets. a) Blood drained from transgenic mouse 
was stained with GPIα-antibody to identify platelets and analyzed in FACS. Depicted is a 
positive transgenic mouse and control littermate. b) Intracardially isolated platelets were 
imaged by TIRFM. Scale bar: 5µm. 
 
 
Furthermore, I addressed the question whether all populations or only specific 
lineages of blood cells were positive for Lifeact expression. To this end, I examined 
different blood cell types of Lifeact-EGFP mice by FACS analysis using specific 
lineage markers to distinguish B-lymphocytes, CD3/CD4+ and CD3/CD8+T-
lymphocytes and myeloid cells. I could observe a strong fluorescent signal in 75 - 95% 
of each cell type (Figure 3.31).  
 
As transgene expression could not be observed in anucleated erythrocytes before, I 
performed FACS analysis on reticulocytes which are erythrocyte precursors. During 
maturation, erythrocytes pass through an enucleation process leading to loss of many 
proteins – caused by degradation – afterwards. Hence, erythrocyte precursors might 
have expressed Lifeact. However, no fluorescent signal could be detected in TER119-
positive cells – representing reticulocytes - indicating that the transgene was not 
expressed in this lineage (Figure 3.31). Moreover, Okabe et al. reported that 
erythrocytes from their “green mice” - also generated with chicken-β-actin promoter – 
did not show a fluorescent signal (1997). 
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Figure 3.31 FACS analysis of EGFP-fluorescence in different blood lineages. Isolated 
splenocytes were stained for TCRβ-CD8, TCRβ-CD4, B220, CD11b and TER119 and FACS 
analysis was performed. As a control C57/Bl6 mice were used (control splenocytes: grey-
shaded; Lifeact-EGFP splenocytes: black unshaded). 
 
 
In conclusion, I could observe strong expression in all examined hematopoietic cells, 
except for erythrocytes and their precursors. These findings demonstrated that the 
generated transgenic mice can be a valuable source for pre-stained primary cells. This 
is particularly interesting for research on cells which cannot be transfected such as 
platelets. 
 
3.11 Functionality of cells  
 
The data shown so far demonstrated that the generated transgenic mice are suitable 
for examining F-actin dynamics in most cell types. To verify whether Lifeact 
expression affected physiological behaviors of cells, I studied two sensitive read-outs 
for cytoskeletal dynamics: chemotactic migration of dendritic cells and polarization of 
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hippocampal neurons. First, I measured the speed of chemotactic dendritic cells in a 
3D-collagen-assay which resulted in no significant difference between transgenic and 
wildtype cells (paired t-test (two-tailed; Lifeact-EGFP, P = 0.29, n = 3 experiments, 
517 tracked cells; Lifeact-mRFPruby, P = 0.83, n = 3 experiments, 796 tracked cells) 
(Figure 3.32). 
 
 
Figure 3.32 Migration speed quantification of transgenic dendritic cells. Transgenic and 
wildtype dendritic cells were subjected to a 3D-collagen-assay. Migration speed of indicated 
mouse lines is shown relative to control cells. Error bar: +/-SD. Data from at least three 
independent experiments. 
 
Second, polarization of primary hippocampal neurons was characterized. After 
isolation, cells were cultured for three days and then evaluated for polarization stage. 
Fixed cells were stained and Tau-1-positive cells were counted. Analysis revealed that 
Lifeact expression did not alter this process significantly in comparison to wildtype 
cells (Lifeact-EGFP P > 0.05; Lifeact-mRFPruby P > 0.05; Figure 3.33a).  
 
In addition, spine formation was examined in transgenic and wildtype cells after 21 
days in culture. Dendritic spines are small membranous protrusions that typically 
receive input from a single synapse. Formation of dendritic spines is dependent on a 
dynamic actin cytoskeleton. In transgenic cells dendritic spines formed which were 
indistinguishable from those in wildtype cells in number and morphology (Figure 
3.33b). 
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Figure 3.33 Characterization of transgenic hippocampal neurons. a) Cells were isolated 
from mouse hippocampi of transgenic and control mice and maintained in culture for three 
days before quantification of neuronal polarization. (red: stage 1 (no neurites), light grey: stage 
2 (neurites), dark grey: stage 3 (axon and neurites)). (b) Dendritic spines in Lifeact-EGFP 
expressing hippocampal neurons after 21 days in culture, imaged by epifluorescnece 
microscopy. Scale bar: 5 µm. 
 
In conclusion, expression of Lifeact-EGFP or Lifeact-mRFPruby did not affect 
sensitive cellular processes such as neuronal polarization or chemotactic migration of 
dendritic cells. 
 
3.12 Applications of the Lifeact-mice 
 
The investigations on transgenic Lifeact mice clearly demonstrated that they exhibit 
bright and specific labelling of the actin cytoskeleton in nearly all tissues from early 
development on. Moreover, I could show that there are no impairments in processes 
depending on actin such as chemotactic migration of dendritic cells or neuronal 
polarization. I therefore aimed to demonstrate that these mice can be used to study 
processes that have been difficult to approach in the past.  
 
As shown before (see section 3.10), platelets from Lifeact-EGFP mice did express the 
marker. Platelets are enucleated cell fragments, originating from megakaryocytes, and 
are important for blood clotting after injuries. Most of the previous studies on their 
actin cytoskeleton were done on fixed cells using phalloidin as a marker. I now was 
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able to analyze their spreading live. When isolated platelets were seeded on fibrinogen-
coated coversplips, I could observe fast adhesion to the surface with a highly dynamic 
actin cytoskeleton and constantly reorganizing shape until the cells adopted a round 
and flat morphology. In addition, stress fibers could be observed in these cells after 
spreading like previously reported (Figure 3.34; Vidal et al. 2002).  
 
 
Figure 3.34 Transgenic Lifeact-EGFP platelet during spreading. Platelets were isolated 
intracardially and placed on top of fibrinogen-coated glass-bottom dishes. Just before imaging 
by TIRFM, thrombin was added for activation. Scale bar: 2µm; Time in seconds. 
 
 
In a second line of experiments, I found that bone tissue from Lifeact-mice was also 
expressing the marker by investigation of fixed cartilage sections from tibia of 
transgenic embryos. A strong and equally stained tissue with normal morphology 
could be observed (Figure 3.35; McGlashan et al. 2006). As it is a major goal in 
biological research to analyze processes within their physiological environment, the 
Lifeact-expressing bone tissue is predestined for live-cell studies: on the one hand, 
bone tissue of embryos is translucent and only few cells are embedded in an acellular 
matrix, compared to other tissues, making it easily accessible for microscopic imaging. 
On the other hand, the cells are maintained within their natural surroundings 
representing optimal conditions for analyzing various processes. 
 
One particularly interesting process in bone development is column formation of 
chondrocytes which is important for longitudinal bone growth (Woods et al. 2007). 
To date, there is not much known about this process in vivo. Most of the hypotheses 
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were established from investigations of fixed samples as it is not possible to transfect 
cells within the tissue (McGlashan et al. 2006; Raducanu et al. 2009). 
 
 
 
Figure 3.35 Cartilage of Lifeact-EGFP mouse showing a bright F-actin staining. Finger 
bone was prepared of E15.5 embryo and sliced into 100 µm sections. Afterwards these were 
fixed and imaged with confocal microscopy. Scale bar: 50µm 
 
 
Due to the facts that bones are translucent during early development and that explants 
continue to grow in culture, I attempted to visualize chondrocyte column formation 
by fluorescence microscopy. To this end, cartilage sections of the tibia were prepared 
from embryos and glued onto a glass-bottom dish allowing live-cell imaging up to 48 
hours. Hence, I could follow cells moving and undergoing cell division. Strong 
expression of Lifeact in chondrocytes showed their actin organization and dynamics 
during these processes. I could observe cells changing shape and twisting presumably 
with the aid of the highly motile actin cytoskeleton (Figure 3.36).  
However, applying low magnification for visualizing a larger image section led to loss 
in resolution. Therefore, to dissect the molecular details of these processes, 
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particularly concerning the actin cytoskeleton, it would be necessary to use higher 
magnification.   
 
 
 
 
Figure 3.36 Live imaging of bone explant from Lifeact-EGFP transgenic mouse. 
Finger bones were prepared from E16.5 embryo and sections were glued onto a glass-bottom 
dish. Live imaging with spinning disk microscopy could be achieved up to 48 hours. Time: in 
hours. Scale bar: 20 µm. 
 
 
To summarize the second part of my work, I generated Lifeact-EGFP and Lifeact-
mRFPruby transgenic mice which showed almost ubiquitous expression of the marker 
enabling analysis on actin dynamics on tissue and organismic level. Lifeact expression 
was clearly observable in the early development of these mice. I also found a specific 
and strong labelling of actin in isolated cells making them suitable for single-cell 
analyses. Moreover, expression of the marker did not interfere with cellular processes 
such as migration of dendritic cells and neuronal polarization. Finally, I could show 
that processes which were difficult to approach in the past either on single-cell level, 
in the case of platelet spreading, or on tissue level, in the case of bone growth, are 
feasible with Lifeact transgenic mice. Thus, these mice could be a versatile tool for 
research in various disciplines.                           
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4 STATEMENT of  contributions 
 
To give a complete picture of all results during my thesis, I also mentioned some 
experiments where other persons collaborated. In the following table, all 
contributions are listed. 
Experiment Person 
Biochemical assays Dr. Alvaro Crevenna 
Human neutrophil preparation Dr. Kai Kessenbrock 
Oocyte injection Dr. Michael Bösl 
Fertilized oocyte preparation Dr. Minh-Weissenhorn 
Neuronal polarization assay 
Spine development assay 
Dorothee Neukirchen 
Dr. Kevin Flynn 
Murine bone preparation Dr. Aurelia Raducanu 
Dr. Attila Aszodi 
Murine platelet preparation  Florian Gärtner 
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5 DISCUSSION 
 
5.1  Development of a new actin marker - Lifeact 
 
Filamentous actin is involved in many fundamental processes in eukaryotic cells, 
including cell morphogenesis, cell division or cell migration (Pollard & Cooper 2009; 
Sanger 1975; Lammermann et al. 2008). In contrast to the opinion of past decades, it 
has also become clear in the last years that there are actin orthologues present in 
prokaryotes (Jones et al. 2001; van den Ent et al. 2001). Moreover, several diseases can 
be linked to impairments of cytoskeletal functions including Alzheimers disease 
(James R. Bamburg & Bloom 2009), autosomal dominant deafness (Zhu et al. 2003) 
and cancer (Suresh 2007). 
With the central position of actin in cellular organization, it is very important to 
understand the basic principles of each molecular step starting at the lowest level of 
building filaments and ending at complex processes like migration or cell division. To 
this end, much attention has been paid on staining and imaging the actin cytoskeleton 
either in fixed or in living cells and thus, on developing labelling methods. The actin 
binding protein phalloidin, a mushroom phallotoxin, was the first described marker 
for F-actin in fixed and living samples (Faulstich et al. 1973). Although phalloidin 
produces a highly specific and reliable staining of the actin cytoskeleton, there are 
several limitations in use with living cells: because of its actin stabilizing properties 
phalloidin can only be used in small amounts via injection (Schmit & Lambert 1990). 
Moreover, it was reported that cells injected with phalloidin often suffer from toxic 
effects and frequently die as well as alterations in actin distribution and cell motility 
were observed (Cooper 1987; Wehland et al. 1977). Furthermore, it is until today 
difficult to chemically synthesize phalloidin (Wieland et al. 1983) and also needs an 
elaborate isolation procedure from the mushroom itself. 
 
Another established marker is actin itself either as fluorescent protein-tagged version 
transfected into cells or as fluorophore-coupled (e.g. rhodamine) protein injected into 
cells (Flynn et al. 2009; Waterman-Storer et al. 1998). Both approaches have many 
disadvantages: the latter needs an elaborate as well as relatively expensive production 
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of the label-conjugated actin and quantitative analysis is complicated because of the 
difficult control of the fluorescent actin concentration. Actin tagged to a fluorescent 
protein, such as GFP, is in fact easy and cheap to produce and also transfection into 
cells is feasible. However, cells expressing those actin versions exhibit several 
impairments: all described fluorophore-coupled actin versions exhibit reduced 
functionality and it was also demonstrated by others and also in this study that cells 
expressing those versions show altered actin dynamics (Feng et al. 2005; Riedl et al. 
2008). Apart from actin itself as a marker, in the last years researchers often used 
actin-binding proteins or their binding domains to label the actin cytoskeleton in 
different organisms (Edwards et al. 1997; Lenart et al. 2005; Burkel et al. 2007). 
However, several problems also arose using this approach, since these probes often 
stain only subsets of actin structures and upon higher expression exhibit actin 
bundling (Sheahan et al. 2004; Holweg 2007).  
Moreover, one has to keep in mind that all of the above mentioned markers for live-
cell analysis are quite large and may counteract with their endogenous homologs. 
 
These observations clearly demonstrate that there is a need for a better marker for the 
actin cytoskeleton which ideally should have the following properties: i) small size, ii) 
easy and cheap to produce, iii) specific labelling of actin in (all) cells and organisms, 
iiii) no interference with cellular functions. 
In the present work I could show, that the first 17 N-terminal aa (Lifeact) of the yeast 
actin-binding protein Abp140, comprising its actin-binding domain, exhibit a perfect 
labelling of actin structures in comparison to the full-length protein, which was already 
used as actin marker in budding yeast. The Lifeact sequence is the shortest actin-
binding domain described to date and thus, the smallest actin marker used in cells. 
For example, the actin-binding domain of ABP120 (actin-binding protein) from 
Dictyostelium discoideum consists of 65 aa (Pang et al. 1998). In addition, WH2 domains – 
being highly conserved actin binding motifs - found in a variety of proteins regulating 
the actin cytoskeleton lie in a range between 18 and 35 aa (Paunola et al. 2002; 
Edwards 2004). The crosslinker protein moesin (from D. melanogaster) was shown to be 
34 aa long (Edwards et al. 1997).  
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These examples already show significant difference to the actin-binding domain of 
Abp140 in length. Moreover, the binding site and manner of Lifeact might not be 
similar to that of most actin-binding domains. These known domains including WH2-
domains often form short α-helical structures able to bind between the subdomains 1 
and 3 of an actin monomer (Chereau et al. 2005). Although the data in this thesis 
showed, that Lifeact also forms an α-helical structure ranging from residue 2 to 10, 
there was no binding competition with profilin suggesting that the binding site on 
actin lies between subdomains 2 and 4. These results were reminiscent of data on the 
small G-actin binding peptide thymosin β4 which also binds between subdomains 2 
and 4 (Czisch et al. 1993). 
Furthermore, this actin binding domain does not show any sequence homology to 
known proteins. It is therefore less likely that Lifeact interferes with other actin 
regulators also encouraging its use as actin marker in higher eukaryotes. 
 
The next part will address the second criteria for an ideal marker of being cheap and 
easy to produce. Being as short as the Lifeact peptide (17 aa) opens up the possibility 
to profitably chemically synthesize the peptide sequence in a standard peptide 
synthesizer. Afterwards the peptide can be used either without or with modification. 
To perform biochemical assays, for example, researchers might use Lifeact non-tagged 
to avoid interferences of the conjugate. On the other hand, if Lifeact is coupled to a 
fluorescent dye or gold molecules it can be used in various assays such as 
immunofluorescence or cryo-electron-microscopy. This feature makes Lifeact 
competitive to phalloidin – the commonly used actin probe in fixed samples - which is 
difficult to synthesize (Wieland et al. 1983) and is mostly purified from its original 
source, the mushroom Amanita phalloides in an elaborate and expensive way. 
Moreover, Lifeact did not show any toxicity to cells in this study which also is 
advantageous to phalloidin which, as a phallotoxin, stabilizes actin filaments and leads 
to death upon high exposure. Thus, the examined cells and the user of Lifeact are 
more secure by avoiding negative effects on both.  
Upon being non-toxic, Lifeact peptide could also be used in living cells. Particularly, 
when cells are hard to transfect (e.g. oocytes) or non-transfectable (e.g. primary 
neutrophils) using Lifeact yet allows investigation of their actin cytoskeleton by 
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different methods including injection or scrape-loading of the peptide (McNeil et al. 
1984; Li et al. 2008). However, injection requires special equipment and experience, 
for obtaining few stained cells. And also scrape-loading by treating the cells relatively 
rough, may have adverse effects on the processes studied. Thus, there is still potential 
to improve this protocol with other insertion methods, for example proteofection 
(Mammoto et al. 2004; Wang et al. 2009).  
This second criterion is not only true for Lifeact as chemically synthezised peptide but 
also for a genetically encoded version coupled to a fluorescent protein which can be 
expressed in cells. The Lifeact sequence can easily be inserted into different vectors by 
using complementary primers forming double-stranded oligos which can be used in 
ligation reactions. Moreover, by using those chemically synthesized primers, 
improvements such as codon-usage optimization, can easily be achieved. 
 
Although the first two criteria for a good actin marker are fulfilled by Lifeact, one of 
the most important characteristics would be specific labelling of actin. As a basis for 
this investigation, the chemically synthesized peptide was used in biochemical assays. 
These analyses revealed that Lifeact binds to G-actin with rather high affinity (Kd ~ 
70nM) compared to its affinity to F-actin (Kd ~ 2.2 µM). However, with the 
microscopic data of fixed and living cells I clearly showed a high signal-to-noise ratio 
for F-actin staining. There might be several reasons for this opposing result: On the 
one hand, to perform biochemical assays with either monomeric or filamentous actin, 
the state of actin has to be controlled with special buffer conditions. Thus, G-actin is 
handled with low salt concentration (0.1 mM CaCl2) to prevent polymerization 
whereas F-actin is handled with high salt concentration (5 M KCl) to maintain this 
state. Obviously, these conditions are very different and it is not clear how they affect 
the binding constants of Lifeact to F-actin. Nonetheless, examining the FRAP data of 
Lifeact, either as peptide in fixed cells or as EGFP-fusion protein in living cells, it is 
clear that the binding affinity of Lifeact to F-actin is rather low. In comparison to 
EGFP-actin, the recovery was more than 50-fold faster for Lifeact demonstrating a 
high on-off ratio on F-actin confirming the biochemical results. 
On the other hand, it is also important to include the physiological aspect, because the 
concentration of F-actin in vivo is about 3.2-fold higher than G-actin – 500µM and 
Discussion 
 
 - 76 - 
150µM (in lamellipodia of fibroblasts), respectively (Koestler et al. 2009). So, if each 
actin molecule binds to Lifeact, the concentration of Lifeact is also 3.2-fold higher on 
F-actin than on G-actin. Admittedly, the latter factor alone might not be enough to 
explain the high signal-to-noise ratio seen in Lifeact-expressing cells. Based on the 
observation that Lifeact could bind to actin monomers in a similar way as Thymosin-
β4 (Czisch et al. 1993), in a cellular environment the latter might also compete with 
Lifeact for binding to G-actin. This competition would strongly reduce the amount of 
G-actin to which Lifeact could bind. Hence, to test this hypothesis it would be 
necessary to analyze the binding of Lifeact to G-actin in the presence of Thymosin-β4. 
Furthermore, there might also be other G-actin binding proteins or cellular factors 
which could affect the binding of Lifeact which were not taken into account yet.  
 
The next step was to investigate the labelling quality of Lifeact as actin marker in cells 
and tissues, in particular, compared to established markers. Notably, almost perfect 
co-localization with either phalloidin – in fixed samples – or fluorophore-tagged actin 
– in living cells – could be observed. Moreover, we found very low background signals 
(meaning cytosolic fluorescence) in these samples leading to a high signal-to-noise 
ratio and bright visualization of F-actin. Although the data showed, in the biochemical 
assays, that Lifeact has a 30-fold higher affinity to G-actin than to F-actin, the 
microscopic data demonstrated that this marker exhibits a very specific labelling of 
filamentous actin in cells. As one more striking result from these experiments, I could 
not observe any known actin structure in the examined cells which was not stained by 
Lifeact. For example, strongly bundled filaments such as in stress fibres were equally 
well labelled as the fine, rapidly reorganizing branched network in lamellipodia of 
migrating dendritic cells. Another remarkable finding was that transfected primary 
neurons showed a perfectly labelled actin cytoskeleton with normal morphology as 
these cells are very sensitive to disturbances. 
 
In conclusion, the in vitro results concerning the binding affinities of Lifeact to G- and 
F-actin do not doubtlessly show the specificity of Lifeact for F-actin; however, the 
microscopic data convincingly demonstrated Lifeact’s high labelling quality of F-actin 
in various approaches.  
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In the next paragraph, regarding the last, but most important criterion of a good actin 
marker – no interference with cellular functions - I focused on the effects of Lifeact 
expression in cells also relating to other established markers. 
The results of the biochemical assays showed that Lifeact does not disturb actin 
polymerization or depolymerization kinetics. Moreover, no change in binding affinities 
to G- or F-actin could be seen either with sequestering or with side-binding proteins 
present. These data suggested that Lifeact’s binding site on G- and F-actin is distinct 
from those of other binding partners. Furthermore, these results were promising with 
regard to Lifeact’s effects in living cells on actin dynamics. 
Accordingly, I obtained very positive results in various transfection experiments with 
primary cells and cell lines with the Lifeact vectors including very sensitive samples 
such as dendritic cells and neurons. I also generated several stable cell lines expressing 
the marker on high level with no apparent change in their cellular characteristics.  
 
To quantitatively measure whether the expression of Lifeact leads to impairments in 
cellular functions we analyzed three different processes which are sensitive read-outs 
for cytoskeletal defects: i) quantification of neuronal polarization, ii) retrograde actin 
flow in lamellipodia of fibroblasts, iii) speed of chemotactic dendritic cells in a 3D 
environment. All of these processes are critically dependent on a fully functional 
cytoskeleton (Witte & Bradke 2008, Renkawitz et al. 2009). Neurons, for example, 
have to polarize in order to determine the right and only one axon. Especially, the 
process of breaking the initial symmetry and growth of one neurite – becoming the 
axon – is based on a rapidly reorganizing actin cytoskeleton (Flynn et al. 2009). The 
retrograde actin flow in lamellipodia of fibroblasts reflects the most basic function of 
actin, namely polymerization, and its analysis is able to show slight impairments during 
this process. Finally, the speed of chemotactic dendritic cells represents the same 
function of actin but in a complex environment. During this process, not only actin 
polymerization itself but the interplay between signal transduction from and to the 
cytoskeleton to achieve coordination and directionality is critical for fast and efficient 
reactions when encountering pathogens (Sabatté et al. 2007). 
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It was already known that EGFP-actin as well as other fluorophore-tagged versions 
does not exhibit normal functionality (Yamada et al. 2005). In particular, these fusion 
proteins are not able to form polymers as efficiently as wildtype proteins and integrate 
at only about 1 to 10 subunits in a wildtype actin polymer.  
In line with these findings, it was not surprising that EGFP-actin expressing cells 
showed significantly altered results compared to wildtype cells in all analyzed 
processes. In contrast, expression of Lifeact-EGFP did not lead to significant changes. 
Moreover, generation of transgenic mice using random integration into the genome 
leading to almost ubiquitous expression of Lifeact in phenotypically healthy animals 
demonstrated also great evidence that this actin marker is not interfering with 
substantial cellular functions.  
To conclude, the importance of live-cell imaging of the actin cytoskeleton forced 
researchers to use fluorescently labeled makers such as EGFP-actin at the same time 
accepting the disadvantage of changing cytoskeletal dynamics. Now, using Lifeact, it is 
possible to visualize the actin cytoskeleton not only with a better signal-to-noise ratio 
but, more importantly, with the knowledge of getting a more authentic report of 
cellular processes. 
 
Based on these data, my further goal was to use Lifeact in applications where live 
visualization of the actin cytoskeleton was not possible before. Hence, with respect to 
this issue isolated primary, human neutrophils were examined. 
Neutrophils represent one of the first lines of defense in the human body and are 
fighting against invaders by engulfment or by secretion of anti-microbial proteases 
(Segal 2005). These cells can also contribute to chronic inflammation in a variety of 
human diseases such as autoimmune disorders or hypersensitivity reactions. The 
underlying pathogenic mechanism is mostly the formation of antigen-antibody 
complexes, or so called immune complexes (ICs), which trigger an inflammatory 
response by inducing the infiltration of neutrophils (Jancar & Crespo 2005). The rapid 
polymerization of actin filaments is required at several steps during this process 
including extravasation, chemotaxis and phagocytosis.  
In the past, it remained difficult to study these processes in living cells because 
neutrophils are terminally differentiated and therefore non-transfectable. In addition, 
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non-activated cells have a short lifespan of only 24 hours, which decreases after 
isolation. Therefore, researches used either fixed samples immuno-stained for actin or 
the myeloid cancer cell-line HL-60 which can be differentiated into neutrophil-like 
cells  (Huang et al. 2008; Rossy et al. 2009; Weiner et al. 1999). The latter is 
transfectable and can be used for live-cell microscopy; however, these cells are not 
fully comparable to primary cells upon passing through several genetic changes for 
reaching an immortalized state (Collins et al. 1977). 
Hence, to achieve labelling of the actin cytoskeleton in living human neutrophils, they 
were scrape-loaded to transfer the FITC-Lifeact peptide into these cells (McNeil et al. 
1984). Remarkably, this approach allowed me to image and analyze actin dynamics in 
living primary neutrophils for the first time. Moreover, the process of IC-mediated 
spreading could be followed, in which the cytoskeletal reorganization plays a major 
role (Tang et al. 1997).  
Thus, also due to its small size, the chemically synthesized Lifeact peptide could be 
used to label living cells independently of genetic approaches and allowed 
investigation of actin dynamics where it was not possible before. However, the used 
method “scrape-loading”, although being fast and efficient, implicates a rough 
treatment of the cells leading to small lesions in the cell membrane. This treatment 
could potentially lead to cellular alterations. For that reason, it would be necessary to 
test other methods for transferring the Lifeact peptide into cells such as proteofection 
and electroporation which were already used successfully for other peptides 
(Mammoto et al. 2004; Todorova 2009). 
Other approaches for fluorescently labelling living neutrophils (or other non-
transfectable cells) may also be considered such as nucleofection or viral transduction. 
Johnson et al. (2006) showed that nucleofection of plasmids, whereby the DNA is 
directly delivered into a cells nucleus, led to protein expression after 2 hours; however, 
with very low efficiency (about 1 %) limiting this method to single-cell based 
experiments. In another approach, transduction of lentiviral-based vectors resulted in 
higher efficiency of protein expression (Dick et al. 2009). However, this method 
requires laborious cloning into specific vectors as well as time-consuming and 
potentially hazardous procedures for viral infections. 
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Taken together, it could be conclusively shown that Lifeact - in its chemically 
synthesized form - can be used for various applications either in biochemical assays or 
as non-toxic alternative to phalloidin for immunostainings of fixed cells and tissues. 
Moreover, because of its small size and non-toxicity, this peptide could even be used 
for labelling the actin cytoskeleton in living cells.    
 
5.2  Generation and characterization of Lifeact-transgenic mice 
 
Although I could demonstrate that Lifeact can be used in versatile applications either 
as genetically encoded version or as chemically synthesized peptide, there are still 
several limitations to its use. On the one hand, for microscopic analyses of single cells 
researchers are dependent on cells which can be manipulated either genetically by 
means of transfection or transduction or mechanically including scrape-loading and 
injection. Although common cell lines such as NIH/3T3 or MDCK are transfectable, 
this method is not successful for most primary cells, e.g. cytotoxic T-Lymphocytes or 
primary bone marrow macrophages (Martin et al. 2007; Wang et al. 2006), and 
researchers require more elaborate techniques such as viral transduction. As discussed 
before, this method needs laborious cloning of special vectors and the transduction 
procedure is time-consuming and potentially hazardous. Also, mechanical 
manipulation methods have several drawbacks: as mentioned before, scrape-loading is 
a rather rough treatment of the cells potentially leading to alterations in cellular 
behavior. Advantageous for injection is, that this method can be used for delivering 
either DNA or mRNA or protein into cells (Lenart et al. 2005; Linney et al. 1999; 
Sheng et al. 2005); however, it depends on specialized and expensive equipment, good 
expertise and large cells, e.g. oocytes (Lenart et al. 2005).   
Furthermore, several questions cannot be addressed using single-cell based assays, for 
example, when focusing on whole tissues or embryonic development. These 
approaches also take into account the physiological 3D-environment which is often 
crucial for cellular behavior (Lammermann et al. 2008). Moreover, many disease 
models can only be studied on organismic level. The most common way to investigate 
those issues is by using transgenic animals (Frock 2006; Hallahan et al. 2004).  
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As research focuses on understanding the molecular and general mechanisms in health 
and disease state in humans, it is important to use model organisms which are closely 
related, such as the mouse. Hence, I pursued this strategy in the generation of 
transgenic mice using the two Lifeact versions described before, coupled to either 
EGFP or mRFPruby.  
 
There are two well-established ways of generating genetically modified mice: either by 
blastocyst injection of embryonic stem cells (= chimeric mice) or by pronuclear 
injection of DNA (= transgenic mice). Generation of chimeric mice requires 
embryonic stem cells stably expressing the protein of interest. Mainly, site-directed 
targeting of a specific locus is used for the integration of the DNA into their genome, 
e.g. the ROSA26 locus (Mao et al. 2001). The insertion site and copy number is then 
verified by southern blot analysis and sequencing. Positive cell clones are implanted 
into wildtype blastocysts which grow to adults harboring two distinct cell populations. 
Finally, these mice are analyzed whether their germline cells express the protein of 
interest to obtain mice with stable and ubiquitous expression. Hence, this is a time-
consuming and laborious method but reliable on the level of insertion site and copy 
number which is particularly important for the generation of knock-out mice. 
The other approach - which was used in this study - utilizes microinjection of the 
foreign DNA directly into the pronuclei of fertilized oocytes. Afterwards these 
oocytes are implanted into pseudo-pregnant mice giving birth to potential transgenic 
mice. This method leads to random integration of the foreign DNA into the genome 
thereby eventually damaging other genomic sites as well as inserting in a highly 
variable gene copy number (Ittner & Gotz 2007). Thus, each pup represents a putative 
founder which has to be treated as an independent subline and analyzed carefully to 
choose the one with the best expression pattern and a healthy phenotype. In contrast 
to conditional knock-in strategies – whereby gene expression can be switched on in 
defined conditions, e.g. age-dependently or cell lineage-specificly (Jonkers & Berns 
2002) - , I used the chicken-β-actin promoter which led to ubiquitous expression of 
the transgene as reported by Niwa et al. (1991). Using this strategy I obtained putative 
founders that were viable, fertile and phenotypically normal in comparison to wildtype 
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mice suggesting that neither insertion site of the transgene was affecting important 
cellular processes.  
Pups of each putative founder showed a high variability in transgene expression. 
Hence, this result indicates that the transgene inserted into a different locus in each 
case with a different expression profile which was expected upon the used method 
leading to random integration into the genome and variations in copy number. 
 
With counterstaining of fixed cryosections with phalloidin and TIRF microscopy of 
isolated, living cells, all putative founders were analyzed whether the fluorescent signal 
corresponds to F-actin. These analyses revealed a specific and bright staining of the 
actin cytoskeleton in all positive organs and isolated cell types of Lifeact-EGFP mice.  
However, seven out of the ten Lifeact-mRFPruby mice did not show a specific F-actin 
staining but rather aggregates of the fusion protein.  These complexes also exhibited a 
bright fluorescent signal and therefore appeared as false-positive. An oligomerisation 
tendency was reported for other RFP versions indicating a similar problem for Lifeact-
mRFPruby (Day & Davidson 2009). The three residual founders showed even 
labelling of their actin cytoskeleton and could be used for further analyses. Due to the 
fact that a high amount of various RFP versions leads to more aggregation (Mizuno et 
al. 2001), this study also shows that the locus of integration as well as the copy number 
influences the functionality of the transgene. As the surrounding of the integration 
locus has strong impact on expression levels (Madan Babu et al. 2008) this difficulty 
could be overcome either with site-specific integration of the transgene or with a 
weaker promoter than the CAG, e.g. the PGK or SV40 promoter (Qin et al. 2010).  
 
To evaluate whether all cells of one type are positive, I performed flow cytometric 
analysis of different blood cell populations which revealed that about 80 to 90% of 
each cell type showed a fluorescent signal. Moreover, the flow cytometric analyses 
revealed that the fluorescent signal was at least two to three log shifts brighter than in 
control cells.  
These results were striking because the only available transgenic mouse with almost 
ubiquitous - except skeletal muscle tissue - EGFP-actin expression (Gurniak & Witke 
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2007) does not exhibit an as bright fluorescent signal in isolated dendritic cells and 
neurons (personal communication: Dr. Michael Sixt and Dr. Frank Bradke).  
 
Since erythrocytes appeared to be negative in microscopic analysis, I wondered if their 
precursors did express the transgene. Erythrocytes loose most of the cellular 
organelles including the nucleus during maturation and have a life-span for about 55 
days in mice. Due to these facts, many proteins are degraded shortly after maturation 
and cannot be detected in the majority of mature erythrocytes although they could 
have been expressed in earlier stages (Molecular biology of the cell, Alberts 2002). 
However, using the TER119-antibody which binds to early precursors such as the 
pro-erythroblast (Kina et al. 2000), no fluorescent signal was detected by flow 
cytometric analyses suggesting that the transgene is not expressed in this lineage. 
Ikawa et al. used the same promoter for the generation of “green mice” and also 
reported negative red blood cells indicating that this promoter is only weakly active or 
inactive in these cells (Ikawa et al. 1998).  
 
By investigation of different embryonic stages after fertilization during embryo 
development, I found almost no fluorescent signal in fertilized oocytes (time point 
E0.5). This can arise from two reasons: either the transgene is not expressed at this 
stage or the protein level is much too low for imaging. However, from time point E1.5 
up to E15.5 I could observe a fluorescent signal which was bright enough for 
visualization with standard widefield optics. Moreover, no morphological defects 
could be observed in all examined embryos. Based on these observations, I concluded 
that expression of Lifeact-EGFP or Lifeact-mRFPruby in higher levels does not 
interfere with mouse development making these mice a valuable tool in developmental 
research. However, they might not be suitable when focusing on oocytes, fertilized or 
unfertilized. This drawback could be overcome by using a different promoter with 
sufficiently strong expression in this stage such as the ICAM-1 promoter (Lu et al. 
2002). 
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5.3  Possible applications 
 
All data shown before convincingly demonstrated that these transgenic mice represent 
a novel, versatile tool for studying F-actin dynamics in many fields. However, I also 
wanted to prove its applicability with two specific examples: i) imaging actin dynamics 
during platelet spreading and ii) visualization of chondrocyte growth in a bone explant. 
 
Blood platelets are crucial for wound repair in the body. Once an injury occurs these 
cells aggregate to form a thrombus to close the wound and stop bleeding (Figure 5.1a, 
b). In addition they secrete different factors to promote wound closure. They are 
produced by budding off from megakaryocytes as small, differently shaped cell 
fragments without nucleus. Therefore, platelets can not be transfected and most of the 
studies on their actin cytoskeleton were done on fixed cells (Vidal et al. 2002). 
Different actin structures (lamellipodia, filopodia and stress fibers) are fundamentally 
involved in supporting thrombus formation and stability (Hartwig et al. 1999; 
Calaminus et al. 2007). I could demonstrate that platelets isolated from Lifeact-EGFP 
mice exhibit a bright fluorescent signal in both flow cytometric and microscopic 
analyses. Time-lapse imaging with TIRFM revealed a highly dynamic actin 
cytoskeleton during spreading. However, these preliminary experiments do not allow 
conclusions on the importance and function of the actin cytoskeleton during this 
process. Still, they might be a good starting point for further investigation of spreading 
in vitro and in vivo. Moreover, their origins in vivo, the megakaryocytes, were also shown 
to express the transgene by collaborators (Steffen Massberg, TU München). These 
data encourages research on platelets and megakaryocytes, e.g. the budding process of 
platelets.  
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Figure 5.1 Blood clot formation. a) Blood clotting normally is triggered by damage to a blood 
vessel. Platelets then immediately begin to adhere to the damaged part of the vessel and release 
chemicals to attract more platelets. A platelet plug is formed, and the external bleeding stops. 
Next, clotting factors cause strands of blood-borne material, called fibrin, to stick together and 
seal the inside of the wound. Eventually, the damaged blood vessel heals, and the blood clot 
dissolves after a few days. b) A whole blood clot is made up of a branched network of fibrin fibers 
(blue), platelet aggregates (purple), and red blood cells. 
Source Image       a):   New York Times, 01.08.2007 
b):  Nature Cover, 413 (6855) 
 
 
The formation of endochondral bones requires cartilage as a template which contains 
the so-called chondrocytes. Some of these cells differentiate into proliferative and then 
hypertrophic cells and are located in the growth plate (Figure 5.2). The proliferative 
chondrocytes undergo strictly regulated, unidirectional proliferation resulting in highly 
organized columnar structures. This whole process is responsible for the longitudinal 
growth of long bones (van der Eerden et al. 2003) and occurs in mice at 15.5 to 17.5 
days post-coitum. It has become evident that, especially during chondrocyte 
differentiation, the actin cytoskeleton plays a major role (Woods et al. 2007). However, 
conclusions on this process were made from studies performed on fixed tissues and it 
is still not clear how these columnar structures are established in such a highly 
organized manner.  
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Figure 5.2 Column formation of chondrocytes during bone growth. Endochondral 
ossification requires the formation of a transient cartilage template. Chondrocytes in the most 
central region of the template differentiate to the terminal stage of the hypertrophic chondrocyte. 
Chondrocytes located between the resting/reserve zone and the hypertrophic zone proliferate in 
an unidirectional manner, resulting in characteristic columns. The regions on either side of the 
bone tissue are termed the growth plates and responsible for longitudinal growth.  
 
Source Image: Woods et al., 2007 
 
 
Through combination of the two facts that bone explants of transgenic mice exhibited 
a bright actin staining and the possibility of maintaining those explants in culture, 
video-microscopy of living, growing bones could be achieved. Moreover, for the first 
time it was possible to follow dividing and moving cells in the growth plate. Although 
the time–frame was too short to observe the whole process of column establishment, 
this approach was very promising for gaining deeper insights.  
Particularly, if chondrocytes divide randomly orientated with subsequent migration to 
maintain the structural order or if the division orientation is predefined could be 
figured out by using this live-imaging technique. However, to investigate the role of 
the actin cytoskeleton and the mechanisms behind in more detail, it will be necessary 
to use higher magnification. 
 
In conclusion, by imaging non-transfectable platelets and chondrocytes, I could 
demonstrate that the generated transgenic mice can be a powerful tool for previously 
restricted research on actin dynamics in living organisms or explants. 
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6 MATERIAL and METHODS 
 
6.1 Material 
 
6.1.1. Chemicals and Reagents 
 
Component Origin 
Acetic acid 100%  Merck 
Agarose Invitrogen 
Ampicillin  Carl Roth 
ARTISS fibrin sealant Baxter Healthcare 
BSA PAA Laboratories 
CCL19 R&D Systems 
CloNat  Werner BioAgents 
Concanavalin A Carl Roth 
D(-)-Sorbitol reinst  Merck 
D(+)-Glucose  VWR 
Desoxynucleotide Solution Mix  New England BioLabs 
Dextran T500 Pharmacia Biotech 
Difco Bacto Agar  Becton, Dickinson and Company 
Difco Bacto Pepton  Becton, Dickinson and Company 
Difco Trypton  Becton, Dickinson and Company 
Difco Yeast Extract  Becton, Dickinson and Company 
Dimethylsulfoxid  Sigma-Aldrich 
DMEM Invitrogen 
EDTA Merck 
Ethanol puriss.  Sigma-Aldrich 
Ethidiumbromide-solution (1%)  Carl Roth 
Fetal calf serum Invitrogen 
Fibrinogen Sigma-Aldrich 
Fibronectin Calbiochem 
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Formaldehyd  Merck 
GeneRuler™ DNA ladder Mix (100bp-10kb)  Fermentas 
Geneticin (G418) PAA Laboratories 
Glycerol Merck 
Glycine Riedel-de Haen 
Hanks’ balanced salts Sigma-Aldrich 
hCG Intervet 
Heparin Sigma-Aldrich  
Interleukin-2 Peprotech  
Isopropanol  Merck 
KCl Merck 
KH2PO4 Merck 
L-Glutamine PAA Laboratories 
Ligation buffer  New England BioLabs 
Lipopolysaccharide (E.coli LPS 0127:B6) Sigma-Aldrich 
MEM EAA Invitrogen 
MEM NEAA Invitrogen 
Methanol Fisher-Scientific 
Methionine  VWR 
Muscle actin Cytoskeleton 
Na2CO2 Merck 
Na2HPO4 x 2xH20  Merck 
NaCL Merck 
Non-muscle actin Cytoskeleton 
Ovalbumin, grade-V Sigma-Aldrich 
Pancoll PAN Biotech 
Penicillin/Streptomycin PAA Laboratories 
Pfu DNA Polymerase  Fermentas 
Phalloidin-Alexa488 Invitrogen 
Phalloidin-Alexa560 Invitrogen 
Phenol Red Solution Sigma-Aldrich 
PMSG Intervet 
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Poly (I) Poly (C) Amersham Biosciences 
PolyL-Lysin Calbiochem 
Protease inhibitor tablet Roche 
Proteinase K Sigma-Aldrich 
PureCol INAMED  
Pyrene-actin Cytoskeleton 
Restriction enzymes  New England Biolabs 
RPMI 1640 Invitrogen 
SDS Carl Roth 
Sheared Salmon Sperm DNA (ssDNA)  Eppendorf 
Sodium deoxycholate monohydrate Sigma-Aldrich 
T4-DNA-Ligase  New England BioLabs 
Taq DNA Polymerase  New England BioLabs 
Thrombin Sigma-Aldrich 
Tris Base  Sigma-Aldrich 
Triton-X-100 Serva 
Trypsin (100x) PAA Laboratories 
Tumor-necrosis-factor α (TNFα) Biosource 
UltraPure agarose  Invitrogen 
Water bidest.  Millipore Water System 
Yeast Nitrogen Base w/o Aminoacetat  Becton, Dickinson and Company 
α-actinin  Cytoskeleton 
β-Mercaptoethanol Sigma-Aldrich 
 
6.1.2. Media 
 
Medium Ingredients 
YT-Media 
 
 
 
 
  
0.8% (w/v) Bacto-Trypton 
0.5% (w/v) Bacto-Yeast-Extract 
0.5% (w/v) NaCl 
in ddH2O 
with Ampicillin: final conc. 100μg/ml 
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YT-Plates 
 
  
 
YPD-Media 
 
 
 
 
  
 
SC-Media (Minimal media) 
 
 
 
 
  
SC-Plates  
 
 
 
 
R10 medium 
 
  
 
 
R20 medium  
 
 
 
 
 
YT-Media 
1.5.% (w/v) Agar 
with Ampicillin: final conc. 100μg/ml 
 
2% (w/v) Bacto-Peptone 
1 % (w/v) Bacto-Yeast Extract 
2% (v/v) Glucose 
in ddH2O 
with CloNat: final conc. 300 μg/mL 
with Geneticin: final conc. 100 μg/mL 
 
6.7% (w/v) Bacto-Yeast Nitrogene Base 
w/o respective aminoacids 
in ddH2O 
with CloNat: final conc. 300 μg/mL 
with Geneticin: final conc. 100 μg/mL 
 
SC-Media 
2 % Agar (w/v) 
with CloNat: final conc. 300 μg/mL 
with Geneticin: final conc. 100 μg/mL 
 
RPMI 1640 
10% FCS  
5% Penecillin/Streptomycin  
5% L-Glutamine  
 
RPMI 1640  
20% FCS  
5% Penecillin/Streptomycin  
5% L-Glutamine  
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D10 medium 
 
 
 
Freezing medium  
 
 
KSOM embryo culture medium 
DMEM 
10% FCS 
5% Penicillin/Streptomycin 
 
90% FCS  
10% DMSO 
  
95 mM NaCl 
2.5 mM KCl 
0.35 mM KH2PO4 
0.2 mM MgSO4x7H2O 
10 mM Na-Lactat (60% syrup) 
0.2 mM Glucose 
25 mM NaHCO3 
1.71 mM CaCl2x2H2O 
1 mM Glutamine (GlutamaxI) 
0.01 mM EDTA 
1 mg/ml BSA 
0.5 x NEAA 
0.5 x EAA 
5% Penicillin/Streptomycin 
ad 100ml ddH2O 
 
 
6.1.3. Solutions 
 
Solution Ingredients 
1 M Phosphate buffer 
 
 
1 M Tris-HCl pH 8.0 (25°C) 
 
  
1 M NaH2PO4 x H2O 
1 M Na2HPO4 x 2H2O 
 
1 M Tris in ddH2O 
pH adjusted with HCl 
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PBS, 1x 
 
 
Lysis buffer 
 
 
 
 
 
DNA sample buffer (6x)  
 
 
TBE (10x)  
 
 
 
TAE (50x) 
 
 
 
SORB 
 
 
 
  
PEG-Mix  
 
 
 
 
TE (10x)  
 
 
10 mM Phosphate buffer pH 7.4 
150 mM NaCl 
 
100 mM Tris/HCl pH 8.5 
5 mM EDTA 
200 mM NaCl 
0.2% SDS 
add 100 µg/ml Proteinase K fresh 
 
40% (v/v) Sucrose 
0.25% (w/v) Bromphenol blue 
 
89 mM Tris Base 
89 mM Boric Acid 
0.2 mM Na2EDTA 
 
2 M Tris 
2 M Acetic acid 
50 mM EDTA pH 8.0 
 
100 mM LiOAc 
10 mM Tris/HCl, pH 8.0 
1 mM EDTA/NaOH pH 8.0 
1 M Sorbitol 
 
100 mM LiOAc 
10 mM Tris/HCl, pH 8.0 
10 mM EDTA/NaOH pH 8.0 
40% (v/v) PEG 3350 
 
10 mM EDTA 
100 mM Tris pH 7.5 
RNase (300 μg/μL) 
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Geneticin stock solution 
  
CloNat stock solution 
  
Ampicillin stock solution 
  
ConA solution 
 
 
 
 
RF1 
 
 
 
 
 
  
RF2 
 
 
 
 
 
Low salt buffer 
 
 
 
 
High salt buffer 
 
 
 
200 mg/mL in ddH2O 
 
200 mg/mL in ddH2O 
 
10 mg/mL in ddH2O 
 
0.5 mg/mL Concanavalin A 
10 mM CaCl2 
0.02 % (v/v) NaN3 
in 10 mM Phosphate buffer pH 6.0 
 
100 mM RbCl2 
50 mM MnCl2 x 4 H2O 
30 mM Potassium acetat 
10 mM CaCl2 x 2 H2O 
15 % (v/v) Glycerol 
pH adjusted to 5.8 
 
10 mM MOPS 
10 mM RbCl2 
75 mM CaCl2 x 2 H2O 
15 % (v/v) Glycerol 
pH adjusted to 5.8 
 
0.2 M NaCl 
20 mM Tris/HCl 
1 mM EDTA 
pH adjusted to 7.4  
 
1 M NaCl 
20 mM Tris/HCl 
1 mM EDTA 
pH adjusted to 7.4 
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G-buffer 
 
 
 
 
10x KMEI buffer 
 
 
 
 
10x ME buffer 
 
 
Injection buffer 
 
 
 
 
FACS buffer 
 
 
ACK buffer 
 
 
 
 
Tyrode buffer 
 
 
 
 
 
 
2 mM Tris HCl pH 8.0 
0.2 mM ATP 
0.1 mM CaCl2 
0.5 mM DTT 
 
50 M KCl 
1 mM MgCl2 
1 mM EGTA 
10 mM Imidazole HCl, pH 7.0 
 
 50 µM MgCl2 
0.2 mM EGTA 
 
10 mM Tris/HCl 
0.2 mM EDTA 
in Aqua ad injectabila 
pH adjusted to 7.5 
 
1xPBS 
0.5% BSA 
 
150 mM NH4Cl 
1 mM KHCO3 
0.1 mM EDTA  
pH adjusted to 7.3 
 
10 mM HEPES 
1.4 M NaCl 
26 mM KCl 
121 mM NaHCO3 
0.1% BSA 
0.1% glucose 
pH adjusted to 6.5 or 7.4 
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PHEM fixation buffer 300mM PIPES 
125mM HEPES 
50mM EGTA 
10mM MgCl2 
pH adjusted to 6.9 
 
6.1.4. Kits 
 
Name Origin 
QIAprep Spin Miniprep Kit 
Endofree Plasmid Maxiprep Kit  
QIAquick Gel Extraction Kit  
TOPO TA Cloning Kit 
Mouse T Cell nucleofector Kit 
Qiagen, Hilden 
Qiagen, Hilden 
Qiagen, Hilden 
Invitrogen 
Lonza Verviers 
 
6.1.5. Antibodies 
 
Antibody Species Dilution Origin 
TCRβ-APC  
TER119-PE 
CD4-PE 
CD8-PE 
CD11b-PE 
B220-PE 
GPIα-PE 
Tau-1 (clone PC1C6) 
Alexa-350 (goat) 
Ovalbumin (IgG) 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse 
mouse / rat 
mouse 
rabbit 
1:300 
1:200 
1:200 
1:200 
1:200 
1:200 
1:25 
1:5000 
1:250 
1:1000 
eBioscience 
Pharmingen  
Pharmingen 
Pharmingen 
Pharmingen 
Pharmingen  
Pharmingen 
Chemicon  
Molecular Probes 
Sigma-Aldrich 
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6.1.6. Oligonucleotides 
 
Primer Alias Sequence 
Lifeact-fwd-XhoI RWS648 gatcctcgaggccaccatgggtgtcgcagatttgatcaag 
Lifeact-rev-XhoI RWS649 ctcgagtttgtgatgctattgctttatttgtaacc 
5'-utrophin-mus-XhoI RWS705 ctcgagttatggccaagtatggggacc 
3'-utrophin-mus-BHI RWS707 ggatccttaatctatcgtgacttgctgagg 
5'-mars-ki-mouse RWS801 gctccgaggatgtcatcaaagag 
3'-mars-ki-mouse RWS802 catgaatcttcccacttgaagc 
5'-mouse-GFP-knockin RWS748 gcacgacttcttcaagtccgccatgcc 
3'-mouse-GFP-knockin RWS749 gcggatcttgaagttcaccttgatgcc 
 
6.1.7. Plasmids 
 
Alias Origin Insert Selectionmarker 
RWC510 
RWC514 
RWC547 
RWC551 
RWC553 
RWC572 
RWC576 
RWC577 
RWC553 
RWC578 
RWC590 
pEGFP-N1  
pEGFP-N1  
pCAGGS 
TOPO  
pCAGGS  
pCS2 (Xenopus)  
TOPO 
pEGFP-C1 
pCAGGS  
pCAGGS 
pEGFP-N1 
Abp140-17aa-mRFPruby  
Actin-EGFP 
no Insert 
Lifeact-mRFPruby 
Abp17aa-EGFP  
UtroABD-GFP  
Utro-ABD  
UtroABD-EGFP  
Lifeact-EGFP  
Lifeact-mRFPruby 
Abp140-17aa-EGFP 
Kanamycin 
Kanamycin 
Ampicillin 
Ampicillin 
Ampicillin 
Ampicillin  
Ampicillin  
Kanamycin  
Ampicillin  
Ampicillin 
Kanamycin 
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6.1.8. Organisms 
 
  5.1.8.1 Escherichia coli 
 
For all cloning experiments the strain DH5α was used. This is a derivative of the strain 
K12, which contains the following genetic markers: F’, endA1, hsdR, hsdM, sup44, thi-1, 
gyrA1, gyrA96, relA1, recA1, lacZ.M15. 
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6.2 Methods 
 
6.2.1. Molecular biological methods 
 
6.2.1.1. Plasmid DNA purification 
 
DNA from E. coli was purified using the Qiagen mini and maxiprep systems to 
prepare up to 20/500 µg of plasmid DNA from 2/100 ml bacterial overnight cultures 
in YT-medium containing the appropriate selective antibiotic. The desired plasmids 
were isolated using the appropriate Qiagen kits, mentioned above, according to the 
provided protocols. The resulting plasmid DNA was then used for sequence 
verification or for further cloning procedures after transformation into the E. coli host 
strain DH5α (Birnboim 1983; Bimboim & Doly 1979). 
 
6.2.1.2. Polymerase chain reaction (PCR) 
 
The PCR was performed using a thermocycler (“PXE 0.2”; Thermo Electron Corp.) 
to amplify target sequences (100-1000bp) of a longer DNA molecule. A typical 
amplification reaction includes the sample of template DNA, two oligonucleotide 
primers, deoxynucleotide triphosphates (dNTPs), reaction buffer, magnesium and a 
thermostable DNA polymerase, either the Taq-Polymerase or the Pfu-polymerase. 
The Taq-polymerase was used to amplify DNA, which was not used afterwards (e.g. 
for genotyping) whereas the Pfu-polymerase-amplified sequence was used for further 
steps (e.g. cloning into a expression vector). All PCR reactions were started with a pre-
incubation step termed “Hot Start”, which denatures the template DNA at 95-100°C 
so that the primers can anneal after cooling. The second step, otherwise referred to as 
“annealing”, allows the oligonucleotide primers to anneal to the denatured template by 
lowering the temperature to 50-65°C depending on the annealing temperature of the 
primers. The reaction proceeds with the extension, or elongation of the primers at 
72°C, the optimal temperature for Taq- and Pfu-polymerases. The duration of the 
extension steps are calculated according to the length of the target region and the 
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processivity of the polymerase (1min/1000bp for Taq; 1min/600bp for Pfu). Usually, 
the elongation time of the final cycle is longer (up to 10 minutes) to ensure that all 
product molecules are fully extended. Steps 1-3 constitute one cycle of the PCR. The 
whole PCR reaction is usually carried out in 25-30 cycles. Higher cycle numbers may 
result in an increase of unwanted artifacts, while no increase in the desired product is 
achieved. 
 
Typical amplification reaction: 50 ng Template DNA 
     5 µl 10x Pfu- or Taq-buffer 
     1 µl 10 mM dNTP-Mix 
     0.5 µl forward primer(c=10 pmol/µl) 
     0.5 µl reverse primer(c=10 pmol/µl) 
     2.5 U DNA polymerase 
     ad 50 µl with ddH2O 
 
6.2.1.3. DNA restriction digestion 
 
Restriction digestion of plasmid DNA was performed following a standardized 
protocol for the use of one or more endonucleases. The definition of 1 Unit (U) of 
restriction enzyme activity is the amount needed to completely digest one microgram 
of substrate DNA (often Lambda DNA) in one hour at the optimal temperature 
(usually 37°C). Additionally, each reaction is carried out with a buffer that ensures 
100% activity of the respective endonuclease. As a rule of thumb, the total volume of 
restriction enzyme in the digest should not exceed 10% of the total digest volume, 
which also ensures that the glycerol concentration in the reaction mixture remains 
below 5%. Once all the components, DNA, H2O and buffer, have been added to the 
reaction mix, the endonulease is applied, so it enters optimal reaction conditions. 
Under non-standard conditions, restriction endonucleases are capable of cleaving 
sequences, which are similar but not identical to their defined recognition sequence. 
This process is termed “star” activity, and is completely controllable in the vast 
majority of cases when the enzymes are used under the recommended conditions. 
Cleaving plasmid DNA with two restriction endonucleases simultaneously (double 
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digestion) is achieved by selecting a buffer that provides reaction conditions that are 
amenable to both restriction endonucleases. Choosing the optimal buffer for both 
enzymes should be done carefully under the guidelines supplied by the manufacturer 
(New England Biolabs). Alternatively, if no single buffer is available to satisfy the 
buffer requirements of both enzymes, the reactions should be done sequentially; the 
salt conditions adjusted in between digestions using a small volume of a concentrated 
salt solution to approximate the reaction conditions of the second restriction 
endonuclease. Reactions were stopped by thermal inactivation or by the addition of 
loading-buffer in preparation for gel electrophoresis. 
 
6.2.1.4. Agarose gel electrophoresis 
 
Agarose gel electrophoresis enables the user to monitor restriction digestion or PCR 
procedures, but also to size fractionate DNA molecules in order to purify these from 
the gel. Prior to gel casting, dried agarose is dissolved in buffer by heating and is then 
poured into a self assembled mold, into which a comb is fitted while the mixture is 
still wet. The percentage of agarose in the gel varies. In this work, 1% agarose was 
used, 1,5% agarose gels being necessary for the accurate size fractionation of DNA 
molecules smaller than 100 bp. Ethidium bromide (EtBr) (end concentration: 1 
µg/ml) was included in the gel matrix to enable fluorescent visualization of the DNA 
fragments under UV light. The gels were then submerged in electrophoresis buffer 
(1xTBE) in a horizontal electrophoresis apparatus. After the samples were mixed with 
gel loading dye and loaded into the sample wells, the electrophoresis was initiated by 
applying 100 mV for 30-45 minutes at RT. Size markers are co-electrophoresed with 
DNA samples for fragment size determination. After electrophoresis, the gel was 
placed on a UV light box and the fluorescent ethidium bromide-stained DNA pictured 
using the imaging system GeneFlash from Syngene. 
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6.2.1.5. DNA purification from agarose gels 
 
After electrophoresis, DNA fragments were visualized on a UV light box before being 
removed from the gels by the use of scalpels. Once captured, the DNA was eluted 
from the jellified agarose following the instructions of the “QIAquick Gel Extraction 
Kits” from Qiagen. 
 
6.2.1.6. Determination of DNA concentration 
 
DNA concentration and purity was determined by using the Peqlab 
spectrophotometer “NanoDrop™ ND-1000”. The concentration was determined by 
measuring the absorbance at 260 nm and purity was measured by calculating the ratio 
of absorbance at 260 versus 280 nm. 
 
6.2.1.7. DNA ligation 
 
Purified and restriction enzyme-treated DNA fragments (PCR product) were cloned 
into the desired plasmid vectors, which also have been treated with the respective 
endonucleases producing compatible overhangs. After the vector and insert DNA 
have been prepared and their concentration determined via agarose gel electrophoresis 
a 1 to 3 molar ratio of vector and insert was used for the reaction. All ligations were 
performed with ATP-dependent T4 DNA ligase and the provided buffer (New 
England Biolabs) either 1 hour at RT or overnight at 16°C. Following the reaction, the 
ligated DNA was transformed into an appropriate host strain, here the E. coli strain 
DH5α. 
 
6.2.1.8. DNA sequencing 
 
The sequencing of plasmids was performed by the Microchemistry CoreFacility of the 
MPI of Biochemistry (Martinsried, Germany) using fluorescently labelled nucleotides 
as described by Sanger and colleagues (Sanger et al. 1977). 
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6.2.1.9. DNA isolation from mouse tail biopsies 
 
After placing 0.5 cm of the mouse tail into a microcentrifuge tube, 500µl of Lysis 
buffer were added and incubated at 55°C overnight with gentle shaking. When no 
more tissue is left, the samples were centrifuged for 10 minutes (13.300 rpm, RT) to 
pellet residual hairs. Then, the supernatant was transferred into a fresh tube containing 
400µl isopropanol. After inverting several times, the samples were centrifuged for 5 
minutes (13.000 rpm, RT) and the supernatant was carefully aspirated. 300 µl of 70% 
ethanol was added to each sample and after centrifugation (5 minutes, 13.300 rpm, 
RT) the supernatant was discarded. The pellet was air-dried for ca. 10 minutes and 
dissolved in 300µl ddH2O overnight at 55°C with gentle shaking. 2 µl of each sample 
was used for PCR analysis.   
 
6.2.1.10. DNA preparation for pronuclear injection 
 
As original vector, the pCAGGS plasmid was used and the transgene (either Lifeact-
EGFP or Lifeact-mRFPruby) was inserted through XhoI restriction sites. After proven 
to have the correct sequence, the plasmids were purified with the Endofree Maxiprep 
Kit (Qiagen) to obtain a high amount and clean DNA. After digestion of 25µg DNA 
with AccI and HindIII (Lifeact-EGFP) or AccI and PstI (Lifeact-mRFPruby) the DNA 
fragments were separated in an 0,8 % agarose gel (made with 1x TAE buffer). To 
minimize ethidium bromide contamination of the sample only 10 µg were added to 
the gel.  
After separation, the fragment was cut out with a scalpel and transferred into a dialysis 
bag, filled with running buffer. The dialysis bag was fixed in the running chamber 
across the electric field and electrophoresis was continued for one hour at 80 Volt. To 
force the DNA back from the dialysis wall into the solution the polarity was changed 
for 30 seconds several times. 
Next, the DNA-containing solution was transferred into a 15 ml Faclon tube and 
purified using Elutip-D minicolumns (Schleicher&Schüll). After equilibration of the 
column with 5 ml low salt (LS)-buffer, a 1:2 mixture of the DNA-solution and LS-
buffer was added. After washing the column two times with 5 ml LS-buffer, the DNA 
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was eluted with 400µl high salt-buffer. Ethanol-precipitated DNA was pelleted by 
centrifugation and and washed three times using ice-cold 70% Ethanol. After drying 
the DNA carefully on a 50°C heating block, it was resuspended in 30 µl injection 
buffer and used at a concentration of 100ng/µl. 
 
6.2.1.11. Peptide synthesis 
 
Lifeact peptide was synthesized in the Microchemistry Core Facility of the MPI of 
Biochemistry. In brief, peptides were prepared using solid-phase peptide synthesis on 
a Applied Biosystems 433 A automated peptide synthesizer equipped with 
deprotection monitoring for synthesis control. Preparative RP-HPLC was performed 
to purify the peptide to >90%. 
 
6.2.2. Biochemical methods 
 
6.2.2.1. Actin binding assay 
 
Polymerization of actin was induced by addition of 0.1xvolume 10x KMEI buffer and 
incubation for > 1h at room temperature (RT). 44 µM of F- Lifeact was incubated 
30min with F-actin and then spun 30min at 350,000xg at room temperature. The 
supernatant was removed and the pellet resuspended in 100 µl of 1x KMEI buffer. 
The amount of peptide was measured in a Cary Eclipse Fluorescence 
Spectrophotometer with excitation / emission set for FITC at 495 nm / 520 nm. The 
bound/total ratio was calculated as the signal from the pellet divided by the total 
signal. The Kd was obtained by fitting to a hyperbolic curve. 
Binding to G-actin was determined from a spectral scan of pyrene actin in the 
presence of varying amounts of F-Lifeact. Averages of 5 emission scans between 370 
nm and 500 nm were used with excitation set to 365 nm. The bound/total ratio was 
calculated from the absolute emission difference at 385 nm between a given Lifeact 
concentration and the control divided by the maximum difference observed. The Kd 
was obtained by fitting to a hyperbolic curve. 
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6.2.2.2. Actin polymerization and depolymerisation assay 
 
For polymerization assays, 20% pyrene-labelled actin was centrifuged at 350,000 x g 
for 30 min at 24C° to remove any nucleation seeds. Ca to Mg exchange was done 
adding 0.1xvolumes of 10x ME buffer for 2min. Polymerization was promoted by 
addition of 0.1xvolumes 10x KMEI buffer. The final volume was 100 µl. Pyrene 
fluorescence was monitored with the Cary Eclipse Spectrophotometer with excitation 
at 365nm and emission at 407 nm. To test the effect of F-Lifeact on polymerization 
different amount of F-Lifeact were added to the pyrene-actin after centrifugation and 
incubated for 5min. Depolymerization was measured by monitoring pyrene 
fluorescence after diluting 100% pyrene-labelled F-actin in 1x KMEI buffer to < 0.2 
µM. To test its effect on depolymerization the indicated concentrations of F-Lifeact 
were pre-incubated with F-actin for 5 min before dilution. 
 
6.2.2.3. Far UV CD Spectroscopy 
 
A Spectroscopolarimeter Jasco J-715 was used with the following settings: Nitrogen 
(N2) flow at 9 L/min, Scan speed at 50nm/min, Bandwidth and Data pitch 1nm, 
Continuous scanning mode and 1mm cuvette path length. Wavelengths were scanned 
from 260 to 190 nm. 20 scans were averaged and corrected for buffer signal. CD 
Buffer was PBS 10x diluted with ddH2O at pH 7.1. The mean residue ellipticity at 
wavelength λ is given by, [ ] ( )100 d m λλθ θ= ⋅ ⋅ ,  where θλ is the observed ellipticity 
(degrees) at wavelength λ, d is the path length (in cm) and m the molar concentration 
(4.4 µM). The units are deg cm2 dmol-1. 
 
6.2.2.4. NMR sample preparation and Spectroscopy 
 
For NMR F-Lifeact was dissolved in PBS pH 7.1. Unlabelled Lifeact was dissolved in 
PBS at pH 3. In order to stabilize secondary structure of the peptide, 15% (v/v) of 
1,1,1,3,3,3-hexafluoro-2-propanol-d2 (HFP-d2) was added to the sample of the 
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unlabeled peptide. 10% of D2O (v/v) was added to all samples. NMR measurements 
were carried out at 600 MHz on a Bruker DRX-600 spectrometer equipped with a 
cryoprobe at 300K. 2D nuclear Overhauser effect (NOESY) spectra were carried out 
with mixing time of 100 ms, and total correlated spectroscopy (TOCSY) spectra were 
recorded with DIPSI2 mixing sequence of 35 ms and 80 ms duration (for the 
unlabeled peptide solution in alcohol and labelled peptide dissolved in PBS, 
respectively). Water suppression was carried out using the WATERGATE sequence. 
Sequence specific resonance assignments were carried out as in (Czisch et al. 1993). 
Amino acids spin systems were identified by analysis of TOCSY spectra. NOESY 
spectra were used to observe contacts <5 Å (Wüthrich 1987). 
 
6.2.3. Cell culture methods 
 
6.2.3.1. Cultivation of mammalian cells 
 
Cell culture was carried out in a sterile bench (HERAsafe®, Thermo scientific) 
applying sterile working techniques. If nothing else is indicated, cells were cultivated at 
37°C, 5% CO2 and 95 % humidity (Heraeus® BBD 6220 incubator, Thermo 
scientific), and centrifugation was carried out at 1200 rpm (Heraeus® multifuge S1, 
Thermo scientific) for 5 minutes. 
 
6.2.3.2. Freezing and thawing of cells 
 
Cells were centrifuged and medium was completely aspirated. They were then 
resuspended in ice-cold freezing medium, transferred to Cryo-tubes (Greiner bio-one 
GmbH, Germany) and immediately placed on ice. All cells were stored at -80°C for 
short-term (up to 6 months) and in liquid nitrogen for long-term maintenance. 
 
Thawing of cells was achieved in a 37°C waterbath and they were then immediately 
poured into 10 ml medium. After centrifugation the cells were resuspended in medium 
and plated into culture flasks. 
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6.2.3.3. Primary cells 
 
Murine dendritic cells 
 
Dendritic cells are a heterogeneous population of bone-marrow-derived immune cells 
with complex progenitor development in vivo. Nevertheless, dendritic cells can be 
generated from flushed bone marrow suspension and subsequently differentiated in 
vitro with GM-CSF as described (Lutz et al., 1998). Shortly, bones are flushed with R10 
medium and the resulting bone marrow solution is washed with R10 medium. 2.5x106 
cells are then taken into culture into a 10cm cell culture dish containing 10ml of 
R10/10% GM-CSF. At day 3, 10ml of R10/20% GM-CSF were added and at day 6, 9 
and 12 10ml of the supernatant was replaced by 10ml R10/20% GM-CSF. To finally 
mature the dendritic cells by mimicking a bacterial infection, 200ng/ml 
lipopolysaccharide (LPS) was added over night at day 8-12 of culture. 
 
Murine skin fibroblasts 
 
Cell culture dishes (Falcon) were coated overnight with 1%-gelatine-solution (in 
1xPBS) at RT which was aspirated shortly before use. A piece of skin was placed on 
the dish in Dulbecco´s modified Eagle´s medium (DMEM) supplemented with 10% 
fetal calf serum (FCS) and 5% Penicillin/Streptomycin. After 7 -14 days fibroblasts 
migrated out of the tissue and could be cultured for about 4 weeks. For TIRFM they 
were transferred onto glass-bottom dishes (MatTek Corporation, USA).  
 
Murine T-lymphocytes 
 
The spleen was dissected and squeezed through a cell strainer to obtain a single cell 
suspension. The cells were maintained in RPMI1640 supplemented with 10% FCS, 
5% L-Glutamine and 5% Penicillin/Streptomycin and activated with 2-4 µg/ml 
ConcanavalinA (ConA) on day 0 – 3. Afterwards the ConA was replaced with 100 
U/ml Iinterleukin-2 (IL-2) though the cells could be maintained in culture about 2-3 
weeks.  
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Murine platelets 
 
Mice were anesthetized by inhalation of isoflurane, and 850 µL whole blood was 
collected by cardiac puncture into syringes containing 150 µL citrate buffer. Thereafter, 
1 mL Tyrode buffer (pH 6.5) was added, and the sample was centrifuged for 20 min at 
80 g. The platelet-rich plasma was pelleted at 1277 g for 10 min. Cells were then 
resuspended in Tyrode buffer (pH 7.4) and adjusted to a final concentration of 1.5 x 
105 platelets in 250 µL. For TIRFM imaging, glass-bottom dishes (MatTek) were 
coated with 200 µg/ml fibrinogen overnight at 4°C and blocked with 1% BSA for 1h 
at RT. After placing the cells on the dish they were treated with mouse thrombin (0.1 
U/mL) to initiate activation and immediately imaged at 37°C. 
 
Rodent hippocampal neurons 
 
Primary hippocampal neurons were cultured as described previously (de Hoop et al. 
1998). In brief, hippocampi of postnatal day 0 mice or rat were dissected, trypsinized 
(0.05 % Trypsin-EDTA) and washed in HBSS containing 7 mM HEPES, pH 7.25. 
Cells were then dissociated with glass Pasteur pipettes and 1-1.3 x 105 cells were 
placed on poly-lysine-coated glass coverslips in 6 cm-Petri dishes containing MEM 
and 10 % heat-inactivated horse serum. The cells were then kept in 5 % CO2 at 
36.5°C. After 6-12 h, the coverslips were transferred to a 6 cm dish containing 
astrocytes in MEM and N2 supplements. 
  
Human neutrophils 
 
Human peripheral blood neutrophils were isolated by density centrifugation using a 
Pancoll gradient. Briefly, 10 ml blood containing EDTA was diluted in 10 ml PBS and 
layered on 10 ml Pancoll. After 30 min centrifugation at 500 g neutrophil were 
separated from the erythrocyte rich pellet by dextran sedimentation. Residual 
erythrocytes were eliminated by hypertonic lysis and after washing in PBS, neutrophils 
were resuspended in RPMI containing 0.5% low endotoxin bovine serum albumin. 
Material and Methods 
 
 - 108 - 
Neutrophil purity was routinely ~95% as assessed by forward and side scatter with 
flow cytometry as well as by morphological analysis. 
 
Mouse whole blood cells 
 
Few blood drops were drained from mouse tail vene into a 1.5ml tube containing ca. 
20µl 100U/ml Heparin (dissolved in 1xTBS) solution and stored in the fridge for up 
to six hours before use. Then, the sample was diluted with 500µl 1xPBS and pelleted 
with 1200 rpm for 5 minutes. Afterwards, 450µl ACK-lysis buffer was added for 5 
minutes at RT and deactivated with 1000µl 1xPBS. After centrifugation (1200 rpm, 5 
minutes) the pellet was resuspended in 200µl FACS buffer and stored on ice in the 
dark until use. 
 
6.2.3.4. Cell lines 
 
Madin-darby canine kidney cells (MDCK) 
 
MDCK cells were a kind gift from Dr. Stefan Busche, AG Dr. Guido Posern. They 
were maintained in D10 following standard procedures. 
 
 
Mouse embryonic fibroblasts (MEF)  
 
MEFs were a kind gift from Dr. Michael Leiss, Department Prof. Dr. Reinhard 
Fässler. They were maintained in D10 following standard procedures. 
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6.2.3.5. Transfection of cells 
 
Dendritic cells 
 
Cells between days 8-12 of culture were transfected with plasmids coding for 
fluorescent fusion proteins using the Amaxa Nucleofector Primary Mouse T-cell Kit 
and the Amaxa Nucleoporator (Amaxa, Cologne, Germany), following the 
manufacturer’s instructions. Generally, 5x106 dendritic cells were centrifuged at 90g 
for 5min and resuspended in 100µl Nucleofector solution. After addition of 4µg of 
plasmid-DNA, the sample was transferred to the provided Amaxa cuvette and 
nucleoporated using the program X-001. The sample was then transferred to 3 ml pre-
equilibrated (5% CO2, 37°C) R10/10% GM-CSF in a 6-well plate and over-night LPS 
stimulation was carried out by addition of LPS at least 2 hours after transfection. 
 
MDCK and MEF 
 
One day before transfection cells were transferred onto glass-bottom dishes (MatTek 
Corporation, USA) so that they will not be confluent the next day. To transfect the 
cells, Lipofectamine™2000 (Invitrogen) was used according to the manufacturer’s 
instructions. Briefly, medium was replaced with 2 ml serum-free Opti-MEM 
(Invitrogen) shortly before transfection. Both, 4µg of plasmid DNA and 10µl 
Lipofecatmine™2000 were mixed with 500µl Opti-MEM and incubated for 5 minutes 
at RT. Thereafter, the diluted DNA and Lipofectamine™2000 were combined and 
gently mixed. After ca. 25 minutes the mixture was added to the cells which were then 
incubated at 37°C for 18-48 hours prior to microscopic analysis. 
 
6.2.3.6. Stable cell lines 
 
To obtain cell lines which stably express a transgene, the medium was exchanged 24 
hours after transfection and 500 µg/ml G418 was added to the new medium. After ca. 
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14 days, stable subclones were isolated and further cultured in the appropriate medium 
containing G418. 
 
6.2.3.7. Scrape-loading of human neutrophils 
 
After purification of neutrophils from whole blood they were resuspended in 
RPMI/0.5%BSA and plated on a 6-well dish. Next, an incubation step with 10-15 
minutes at 37°C was necessary that the cells got into a “migrating” state. It is 
important that the cells did not adhere too strong on the dish to avoid irreversible 
damaging of these. The media was carefully aspirated and 200µl of 250µg/ml Peptide 
in 1xPBS was added. After scraping the cells of the dish they were centrifuged and 
resuspended in serum-free media. For TIRFM, the cells were plated onto glass-bottom 
dishes (MatTek). 
 
6.2.3.8. Immune-complex (IC) induced neutrophil 
activation 
 
To form ICs in vitro, glass slides were coated with 5 mg/ml ovalbumin in 1xPBS 
overnight at 4°C followed by washing and incubation in rabbit anti-ovalbumin serum 
at 50 µg/ml specific IgG for 2 hrs at room temperature. FITC-Lifeact loaded 
neutrophils were subjected to ICs in the presence of 10 ng/ml tumour necrosis factor 
α (TNFα) to study actin reorganization in response to ICs. 
 
6.2.3.9. Preparation of fertilized murine oocytes 
 
For superovulation, Lifeact-positive female mice were injected intraperitoneally with 5 
IU/ml pregnant mare serum gonadotropin (PMSG) and 47 hours later with 5 IU/ml 
human chorionic gonadotropin (hCG). Four hours after the last injection, the mice 
were mated with male wildtype mice overnight. The fertilized oocytes were prepared 
by flushing the oviducts after sacrificing the animals and cultured in KSOM-medium. 
For microscopic analysis they were transferred onto glass-bottom dishes (MatTek). 
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6.2.3.10. In vitro generation of E4.5 Embryos 
 
Isolated fertilized oocytes were incubated in KSOM medium at 37°C for 4.5 days. For 
microscopic analysis they were transferred onto glass-bottom dishes (MatTek). 
 
6.2.3.11. Polarization assay of rodent hippocampal neurons 
 
At 3 days after plating, neuronal cultures were fixed with 4% paraformaldehyde, 4% 
sucrose in PHEM fixation buffer for 20 min, and extracted with 0.1% Triton X-100 in 
PBS for 5 min. After blocking (2% FBS and 0.2% fish gelatin in PBS), the coverslips 
were incubated with primary antibody (in 0.2% FBS, 0.02% fish gelatin in PBS). For 
the identification of axons, a monoclonal anti-Tau-1 primary antibody (clone PC1C6) 
and an Alexa 350 goat anti-mouse secondary antibody were used. Images were 
acquired on an Axiovert 135/135 TV inverted microscopes (Carl Zeiss), equipped 
with standard filters for Green, Red, and UV fluorescence (Zeiss and AHF 
Analysentechnik), using a High performance CCD Camera 4912 (COHU) and Scion 
Image 4.0.2 software. 
6.2.3.12. Flow cytometry 
 
Fluorescence activated cell sorting (FACS) was either carried out to analyze blood cell 
populations for fluorescence-positive cells using a FACS-Calibur (Becton Dickison), 
or carried out for sorting of fluorescence-positive cells using a FACS-Aria (Becton-
Dickinson). 
For the former, total splenocytes were obtained by mincing spleens from transgenic 
and control mice. Myeloid cells were identified as CD11b+, B lymphocytes as B220+, 
helper T lymphocytes as TCRβ+, CD4+ and cytotoxic T lymphocytes as TCRβ+, 
CD8+. Employed antibodies were against the mouse antigens: GPIα-PE, B220 PE, 
CD11b PE, CD4 PE, CD8 PE, TER119 PE, TCRβ-APC (see chapter ???).  
To separate fluorescence-positive cells, they were collected, centrifuged and 
resuspended in FACS buffer. During sorting the positive cells were collected in a 
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collection tube and afterwards resuspended in fresh medium and replated on cell 
culture dishes. Flow cytometric analysis was performed with a FACScalibur and 
CellQuest Pro Software (BD Biosciences). 
 
6.2.3.13. Cell staining for flow cytometry 
 
Single-cell suspension was centrifuged and washed one time in 1xPBS. 0.2-1x106 cells 
were resuspended in 50µl FACS-buffer containing the fluorophore-labeled antibody 
and incubated for 20-30 minutes in the dark. Next, 150µl FACS buffer was added to 
the cells and after centrifugation, they were resuspended in 200µl FACS buffer. The 
samples were stored on ice in the dark till use (max. two hours). 
 
6.2.3.14. Migration assays 
 
Under-agarose migration assay 
 
Cell migration was analyzed in an under-agarose assay. 2.5% UltraPure agarose was 
dissolved in distilled water, heated and mixed with 55°C pre-warmed RPMI/20% FCS 
and 2x Hank’s buffered salt solution at a 1:2:1 ratio, resulting in an agarose 
concentration of 6.25 mg/ml. 1.5 ml of warm agarose-medium mixture was cast in 
glass-bottom dishes (MatTek) and allowed to polymerize at room temperature. After 
30 min of equilibration at 37 °C, 5 % CO2, 1 µl of cell suspension (~ 5x105 cells) was 
injected beneath agarose and dish bottom with a fine pipette tip and time-lapse video 
microscopy recording was started immediately. 
 
3D-Collagen migration assay 
 
PureCol in 1x Minimum Essential Medium Eagle (MEM) and 0.4% sodium 
bicarbonate was mixed with cells in RPMI, 10% FCS at a 2:1 ratio, resulting in gels 
with a collagen concentration of 1.6 mg/ml. Final cell concentrations in the assay were 
1 x 106 cells/ml gel. Collagen-cell mixtures were cast in custom-made migration 
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chambers with a thickness of 0.5–1 mm. After 30 min assembly of the collagen fibers 
at 37 °C, the gels were overlaid with 50 µl of the recombinant chemokine CCL19 (0.6 
µg/ml) diluted in RPMI, 10% FCS. 
 
6.2.4. Mouse work 
 
6.2.4.1. Generation of transgenic mice 
 
To obtain transgenic mice we generated two constructs, originating from pCAG-
vector (Okabe et al. 1997), with a cytomegalovirus enhancer, chicken-β-actin 
promoter, a chimeric intron followed either by the Lifeact-EGFP or the Lifeact-
mRFPruby1 sequence and a poly(A)-tail. Constructs were digested with AccI and 
HindIII (EGFP) and AccI-PstI (mRFPruby), the linearized DNA was injected into 
fertilized oocytes (C57BL6/N x FVB/N (F2)) and transferred into pseudo-pregnant 
females. The insertion of either transgene into the genome was tested in >100 pups of 
each strain by PCR (primers Lifeact-EGFP: fwd: gcacgacttcttcaagtccgccatgcc, rev: 
gcggatcttgaagttcaccttgatgcc; Lifeact-mRFPruby: fwd: gctccgaggatgtcatcaaagag, rev: 
catgaatcttcccacttgaagc). Transgene-positive putative founder mice were mated with a 
129SV/C57BL/6 mouse to test germline transmission of Lifeact. Offspring was 
analyzed directly with a standard UV-hand lamp (for Lifeact-EGFP-mice). 
Alternatively, for Lifeact-mRFPruby mice, a piece of tail was analyzed under a stereo 
microscope (Leica). The two best founders of each strain were used for all 
experiments in this study. All positive founders were mated with 129SV/C57BL/6 
mice. All control animals were of mixed 129SV/C57BL/6 genetic background. The 
mice were bred according to local regulations at the Max Planck Institute of 
Biochemistry. 
 
6.2.4.2. Preparation of embryos and organs 
 
After CO2 suffocation of mice organs were removed, placed in cold phosphate 
buffered saline (PBS, pH 7.4) and immediately imaged with a stereo microscope (Leica 
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MZ16 FA, Leica Microsystems). E10.5 and E15.5 embryos were prepared and imaged 
in the same way. Fertilized oocytes were isolated from pregnant mice and kept in 
culture till E4.5. Epifluorescence images were collected on a Zeiss Axiovert 200M 
stand equipped with a climate control chamber from EMBL. 
 
6.2.4.3. Cryosections of organs 
 
After CO2 suffocation of mice organs were dissected and immediately frozen in 
TissueTek on dry ice. Cryo-sections (8 – 10 µm) were cut and used for histochemistry 
as described before. Phalloidin-Alexa 488 and -Alexa 560 were used to counter stain 
for F-actin. Images were taken on a Zeiss Axio Imager controlled by Axiovision 
software (Release 4.6.3). 
 
6.2.4.4. Preparation of cartilage sections 
 
Tibia isolated from newborn Lifeact mouse was placed into PBS and cleaned from the 
surrounding muscle by fine forceps. The proximal cartilage was separated from the 
bony shaft using a razor blade and serial longitudinal sections of the growth plate 
cartilage were cut on a vibratome (Microm, HM 650) at 100 µm. Tissue slices were 
glued onto plasma treated 35mm glass bottom culture dishes (MatTek) by the ARTISS 
fibrin sealant and overlaid with 3 ml Opti-MEM/10%FCS/10mM Hepes, pH 7.4. The 
samples were cultured in a custom-made climate chamber at 37°C and 5% CO2 for 
12-24 hours during microscopy. 
 
6.2.5. Microscopic methods 
 
6.2.5.1. Epifluorescence microscopy 
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Images of yeast cells were acquired on a Zeiss AxioImager A1 microscope equipped 
with an Olympus 100x/NA oil immersion objective and controlled by Metamorph 
Software (Molecular Devices). 
Images of stained cryosections were aquired on a Zeiss AxioImager Z1 equipped with 
an EC Plan-Neofluar 40x/NA0.75 air objective and controlled by AxioVision 
software (Zeiss, Release 4.6.3). 
Movies of living cells were collected on a Zeiss AxioVert 200M stand equipped with a 
CCD camera (Princeton Instruments) embedded in a climate control chamber from 
EMBL (5% CO2, 37°C, humidified) and controlled by Metamorph software 
(Molecular Devices). 
Movies of 3D-collagen chemotaxis assays were recorded using Axiovert 40 (Zeiss) 
cell-culture microscopes, equipped with custom-built climate chambers (5% CO2, 
37°C, humidified) and PAL cameras (Prosilica, Burnaby, BC) triggered by custom-
made software (SVS Vistek, Seefeld, Germany). The objective used was an A-Plan 
10x/0.25 Ph1 (Zeiss) or 20x/0.25 Ph1 (Zeiss). Speed of dendritic cells was manually 
measured over 2 to 3 hours with Metamorph Software (Molecular Devices). 
 
6.2.5.2. Stereomicroscopy 
 
Images of whole organs and embryos as well as genotyping of the transgenic mice 
(analyzing a tail piece) were performed using a LEICA (Wetzlar, Germany) MZ 16 FA 
stereomicroscope equipped with a PlanApo 1.0x objective and controlled by 
Metamorph software (Molecular Devices). 
 
6.2.5.3. Total internal reflection fluorescence microscopy 
 
Migrating T-cells under agarose and platelet spreading was visualized with an inverted 
Zeiss Axiovert 200M microscope equipped with a total internal reflection setup, 
Coolsnap HQ2 camera (Photometrics) and a Plan-FLUAR 100x/1.45 oil objective 
(Zeiss). 
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TIRF images of yeast cells, neurons, MEFs, MDCK and skin fibroblasts were 
captured on an iMIC-stand from TILL Photonics with a 1.45 NA 100x objective from 
Olympus. Images were collected with an iXon897 EMCCD camera (Andor). The 
setup was controlled by the Live Acquisition software package (TILL Photonics). 
6.2.5.4. Confocal microscopy 
 
Images of stained cryosections were acquired with a LEICA (Wetzlar, Germany) TCS 
SP2 AOBS confocal laser scanning microscope equipped with a LEICA HCX PL 
APO 63x/NA1.4 oil immersion objective and controlled by Metamorph software 
(Molecular Devices). 
 
6.2.5.5. Spinning disc microscopy 
 
Images of cartilage explants were acquired with a CSU10 spinning disc microscope 
(Visitron Systems) equipped with a Plan-Apochromat 40x objective and a CoolSnap 
HQ2 CCD camera and controlled by Metamorph software (Molecular Devices). 
 
6.2.5.6. Image processing and data analysis 
  
All image processing steps were performed with Metamorph software (Molecular 
Devices). Data analysis was performed using Metamorph software, MS Excel and 
GraphPad Prism®. 
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7 ABBREVIATIONS and INITIALISMS 
 
µM Micromolar 
µm Micrometer 
2D Two dimensional 
3D Three dimensional 
aa Amino acid 
ABD Actin-binding domain 
Abp Actin-binding protein 
ADF Actin-depolymerizing factor 
ADP Adenosine-di-phosphate 
Arp Actin-related protein 
ATP Adenosine-tri-phosphate 
BSA Bovine serum albumin 
CAG Chicken-β-actin 
CCL C-C motif chemokine ligand 
CD Circular dichroism 
CD Cluster of differentiation 
CMV Cytomegalovirus 
ConA Concanavalin A 
Cy3 Cyanine dye 3 
DC Dendritic cell 
DIC Differential interference contrast 
DNA Desoxyribonucleic acid 
E Embryonic day 
EDTA Ethylen-diamine-tetra-acetate 
e.g. For example 
EGFP Enhanced green fluorescent protein 
EtBr Ethidiumbromide 
FACS Fluorescence activated cell sorting 
F-actin Filamentous actin 
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FH Formin homology 
FITC Fluorescein-5-isothiocyanat 
F-Lifeact FITC-Lifeact 
FRAP Fluorescence recovery after photoblaeching 
G-actin Globular actin 
GFP Green fluorescent protein 
GPI α Glycosylphosphatidylinositol α 
hCG Human chorionic gonadotropin 
i.e. For example 
IC Immune complex 
Ig Immunglobulin 
IL Interleukin 
Kd Dissociation constant 
kDa Kilo Dalton 
LPS Lipopolysaccharide 
M Molar 
MDCK Madin-darby canine kidney 
MEF Mouse embryonic fibroblast 
mRFP Monomeric red fluorescent protein 
nM nanomolar 
nm Nanometer 
NMR Nuclear magnetic resonance 
OD Optical density 
ORF Open reading frame 
PCR Polymerase chain reaction 
PMSG Pregnant mare serum gonadotropin 
RNA Ribonucleic acid 
rpm Rounds per minute 
RT Room temperature 
SAM S-adenosyl-methionine 
s Second 
SD Standard deviation 
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SDS-PAGE Sodium dodecylsulfate polyacrylamid gel electrophoresis 
TCR T-cell receptor 
TIRFM Total internal reflection fluorescence microscopy 
T-lymphocyte Thymus-derived lymphocyte 
TNFα Tumor necrosis factor α 
U Unit 
UV Ultraviolett 
vs. Versus 
WASP Wiskott-Aldrich syndrome protein 
WH WASP homology 
wt Wildtype 
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